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The nuclear pore complex (NPC) is the gateway to and from the genome. The work presented 
in this thesis is the result of the investigations towards understanding some of the key questions 
affecting NPC biology: How is the NPC built up? Can we dissect different modes of transport 
at the level of the NPC? Does the NPC play a role in the development of cancer? The structural 
localization of some of the components of the NPC, called nucleoporins (Nups), has been 
under intensive study. We have precisely located Nup88 using electron microscopy techniques 
(Chapter 3) and placed in the context of Nup214 and Nup358, the other Nups localized 
exclusively to the cytoplasm (Walther et al., 2002). The close localization of Nup358 in 
relation to the Nup88-Nup214 subcomplex suggested that they are interaction partners. In fact, 
we were able to show this physical relation contributing to the current knowledge of the NPC 
interaction map. Furthermore, the result of this study provides useful information about the 
behavior of the Nup88 and Nup214 as a subcomplex that shows codependence of its 
components on protein stability and NPC targeting, and acts as a building block required for 
Nup358 incorporation.  
Concerning nuclear transport, several lines of evidence suggested that Nup358 plays a role in 
nuclear transport (Lounsbury and Macara, 1997; Singh et al., 1999; Yokoyama et al., 1995). 
We present data revealing that Nup358 indeed plays a supporting role in Nuclear Export Signal 
(NES) mediated export by facilitating the disassembly of the export complex, composed of the 
export receptor CRM1, RanGTP and a NES-cargo, and by facilitating a fast recycle of empty 
CRM1 to the nucleus (Chapter 3). In addition, we have been able to further dissect the export 
disassembly process by using supraphysiological (super strong) NESs which revealed export 
complex intermediates that arrested at Nup358 leading to a less efficient export (Chapter 4). 
This finding has provided the reason why NESs maintained relatively low CRM1 affinity 
during evolution. 
Traditional transport models are unable to explain how such diversity of molecules can cross 
the NPC. More recent quantitative transport models discriminate transport mechanisms basing 
on the actual properties of the transported elements and the NPC itself (Becskei and Mattaj, 
2005). Unfortunately, experimental evidence strengthening these models is missing. We have 
investigated in detail the role of Nup214 in CRM1 export pathways (Chapter 5). We show that 
CRM1-mediated export of preribosomes is dependent on the presence of Nup214, while other 




thought to play an important role in transport (Fornerod et al., 1997; Ribbeck and Görlich, 
2001; Rout and Aitchison, 2001), is not relevant for this function. Instead, targeting of Nup214 
to the NPC and interacting with neighbor Nups are crucial. In conclusion, we have been able to 
discriminate different transport modalities which are mediated by the same transport receptor 
and demonstrate that the characteristics of these pathways are dependent on the transport 
receptor, the NPC and the cargo itself.  
A constitutively activated aberrant tyrosine kinase, NUP214-ABL, is overexpressed in Acute 
Lymphoblastic Leukemia (ALL) (Graux et al., 2004). We postulated that NPC targeting, 
provided by Nup214, is required for activation of Abl activity. We have analyzed the 
subcellular localization of this protein and found that it localizes to the nuclear envelope 
(Chapter 6). By using Nup88 RNAi and Nup214 overexpression on cell lines expressing 
NUP214-ABL, we aimed to alter the stability of this protein in an attempt to inhibit cell 
proliferation. These experiments may provide useful information for the development of 
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As heads is tails 
Just call me Lucifer 
’cause I’m in need of some restraint” 
 
Rolling Stones 







































1. Cellular compartmentalization and the Nuclear Pore Complex 
 
The eukaryotic cell has developed a membrane based system of cellular organization that led to 
the compartmentalization and specialization of the processes necessary to maintain vital 
functions. Most of the genome of the cell is located in the nucleus and separated from the 
cytoplasm by the nuclear envelope (NE). This involves the separation of two processes that are 
coupled in prokaryotes: transcription and translation (Görlich and Kutay, 1999). While genes 
are transcribed in the nucleus, protein synthesis occurs in the cytoplasm. In order to 
successfully express part of the genetic material, many different elements need to shuttle 
between the nucleus and the cytoplasm. Transcription factors or other chromatin remodelling 
proteins are required in the nucleus when activated upon signalling in the cytoplasm or in the 
plasma membrane. They promote transcription of genes in a process that requires the activity 
of complex protein machineries and leads to a messenger RNA (mRNA). Once matured, the 
mRNA itself is required in the cytoplasm where it provides the information necessary to 
assemble a protein. Protein production requires in turn, among other elements, the presence in 
the cytoplasm of ribosomes and transfer RNAs (tRNAs) whose synthesis occurs in the nucleus. 
Furthermore, more than 100 proteins and small nucleolar RNAs (snoRNAs) are involved in 
ribosome formation, which consists on an assembly of multiple ribosomal RNAs (rRNAs) and 
proteins (Warner, 2001). It is evident that compartmentalization implies the establishment of a 
mode of communication between the nucleus and cytoplasm. The Nuclear Pore Complex 
(NPC) is the structure that permits this communication while keeping the integrity of DNA and 
blocking access to the genome of undesired elements.  
NPCs are multiproteinic assemblies that create channels interrupting the double bilayer barrier 
of the NE. These assemblies are linked to accessory components creating a nuclear transport 
machinery that establishes and regulates nucleocytoplasmic communication. Regulation of 
transit between the nuclear and cytoplasmic compartments is critical for the outcome of the 
signalling cascades that govern survival or proliferation (Vinkemeier, 2004; Xu and Massague, 





Figure 1. Scanning Electron Microscopy images of the cytoplasmic (1,2) and nuclear (3,4) sides of nuclear 
envelope preparations containing nuclear pore complexes. Detailed magnifications are shown (2,4). Bars represent 
100 nm. Images courtesy of Terry Allen, Helen Pickersgill and Martin Goldberg.  
 
the amplification and propagation of the signalling cascades (Becskei and Mattaj, 2005). The 
NPC is an integral component of the NE and suffers as well rounds of disassembly and 
reassembly on every cell cycle playing a crucial role in the establishment of the nuclear 
architecture and organization. There is an intrinsic relation between the nuclear transport 
system and chromatin. At the initiation of mitosis, several components of the NPC and the 
transport system are relocated to the kinetochores, where they regulate spindle assembly 
(Belgareh et al., 2001; Kalab et al., 1999; Salina et al., 2003). Furthermore, the interphase NPC 
can control epigenetic gene expression (Galy et al., 2000; Mendjan et al., 2006). Considering 
this privileged situation, it is not absurd to implicate NPC components directly in transcription 
control. In fact, studies in yeast show that production and export of mRNAs are coupled 
processes and that NPC-promoter interactions are linked to gene activation (Aguilera, 2005; 





Figure 2. Schematic representation of a cross-section of the NPC showing the main structural features (Left) and 
the nucleoporin subcomplexes composition (right). Inner (INM) and outer (ONM) nuclear membranes are 
depicted. Adapted from (Hetzer et al., 2005).  
 
2. NPC structure 
 
Electronic microscopy (EM) techniques have provided very useful structural and functional 
information of the NPC (Figure 1), from the first images shown in the 1950s (Afzelius, 1955) 
until the latest published results using modern transmission and scanning electron microscopy, 
atomic force microscopy and cryoelectron tomography (Akey, 1989; Beck et al., 2004; 
Goldberg and Allen, 1993; Stoffler et al., 2003). The overall structure and architecture of the 
NPC (Figure 2) is conserved from yeast to vertebrates diverging only in the size of the 
complex, whose estimated mass varies from ~60 MDa in yeast to a maximum of ~125 MDa in 
vertebrates (Cronshaw et al., 2002). A triple ring model of NPC architecture was proposed 
(Unwin and Milligan, 1982) which presents an 8-fold rotational symmetry (Maul, 1971) and 




Table 1. Summary of all nucleoporins identified including some relevant characteristics. Contains summarized 
data from (Allen et al., 2000; Cronshaw et al., 2002; Hawryluk-Gara et al., 2005; Mansfeld et al., 2006; Ryan and 
Wente, 2000; Vasu and Forbes, 2001).  
a C: cytoplasmic, N: Nuclear, PM: pore membrane b FG: phenylalanine- glycine repeats; RBD: Ran binding domain c copies 
per NPC d (Rout et al., 2000) 
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anchor to a central spoke-ring complex via a coaxial ring. The peripheral structures form 
filaments in the cytoplasmic side and baskets in the nuclear side. In vertebrates, the 
cytoplasmic filaments are ~50nm long (Franke and Scheer, 1970; Franke and Scheer, 1970; 
Richardson et al., 1988) and the nuclear basket protrudes ~100nm from the NE. The central 
channel-like feature contains eight spokes sandwiched between the cytoplasmic and nuclear 
rings with a maximum diameter of 25nm in vertebrates (Cordes et al., 1993; Goldberg and 
Allen, 1992; Jarnik and Aebi, 1991; Ris, 1997). 
Although microscopy techniques provide a static view of the NPC, several studies have been 
able to discriminate conformational states of the NPC which are thought to reflect structural 
modifications during the transport process (Beck et al., 2004; Kiseleva et al., 1998; Stoffler et 
al., 2003). It remains to be established to which, if not all, transport events these 
conformational changes are associated with.  
Very little has been achieved towards the understanding of the NPC structure at the molecular 
level. There are no reports showing the crystal structure of any complete nuclear pore 
component. Some studies have shown discrete domains of Nup358 and Nup214 but, although 
they provided valuable data about their functions individually, they gave very little information 
about the relation of these proteins with the overall structure of the NPC (Geyer et al., 2005; 
Pichler et al., 2004; Reverter and Lima, 2005; Vetter et al., 1999; Weirich et al., 2004). In vitro 
reconstitution of self-associating individual components or complete subcomplexes in 
combination with EM imaging has been used to obtain basic structural information (Buss et al., 
1994; Siniossoglou et al., 2000) but the integration of these data in the overall NPC context is 
difficult and more information is required.  
 
3. NPC composition 
 
The constituents of the NPC are termed nucleoporins or Nups (Table 1). Interestingly, only ~20 
different nucleoporins are required to assemble the NPC indicating that every pore contains 
multiple copies of the same components (Cronshaw et al., 2002; Rabut et al., 2004; Rout et al., 
2000). In fact, the molecular architecture of the yeast and vertebrate NPC revealed by 
immunogold labeling in combination with EM shows that most Nups occupy several positions 
following the rotational symmetry and, with the exception of the peripheral components, a 
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symmetric position within the vertical plane of the NE (Fahrenkrog et al., 2000; Rout et al., 
2000; Walther et al., 2001; Walther et al., 2002). The exact localization of individual Nups 
within the NPC has been sometimes controversial due to several reasons such as technical 
difficulties (antibody specificity, labeling procedure or sample preparation), variability within 
species or cell lines and mobility of some Nups (Krull et al., 2004).  
One major difference between yeast and vertebrate NPC is the mechanical connection to the 
NE. While yeast NPCs are mobile within the NE (Belgareh and Doye, 1997; Bucci and Wente, 
1997), vertebrates have anchored NPCs (Daigle et al., 2001). In relation to their position, 
physical interactions between neighbor Nups have been studied and mapped (Allen et al., 
2002; Huang et al., 2002). Nups associate in subcomplexes prior to incorporation to the NPC 
(Doye and Hurt, 1997; Ryan and Wente, 2000). Some of these subcomplexes or individual 
Nups are well conserved between species but others differ widely or have no obvious 
homologue (Ohno et al., 1998). The dynamic behavior of the NPC components has been 
systematically studied using Fluorescence Recovery After Photobleaching (FRAP) techniques 
on GFP-tagged Nups (Rabut et al., 2004). Interestingly, while some components show a high 
residence time within the NE, others are very mobile revealing that the NPC is highly dynamic 
and that these individual Nups may have additional cellular functions.  
Concerning their primary structure, many Nups present repeated motifs of the sequence FG, 
FxFG- or GLGF-. These motifs present in Nups, termed in general FG-repeats, are believed to 
be responsible for the NPC acting as a selective barrier (Bayliss et al., 2000; Bayliss et al., 
2002; Stewart et al., 2001; Strawn et al., 2004). FG-repeat containing domains are highly 
flexible and lack ordered secondary structure (Denning et al., 2003; Rout and Wente, 1994; 
Ryan and Wente, 2000). Nups containing these repeats could line the translocation channel of 
the NPC and, as will be discussed below, are thought to play an important role in nuclear 
transport (Allen et al., 2001; Buss et al., 1994; Denning et al., 2001; Ribbeck and Görlich, 
2001; Rout and Aitchison, 2001). 
 
4. Nuclear Transport 
 
Intensive research during the last decade has led to the development of a general model of 
nucleocytoplasmic transport (Allen et al., 2000; Bayliss et al., 2000; Görlich and Kutay, 1999; 
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Hetzer et al., 2005; Mattaj and Englmeier, 1998; Weis, 2003; Wente, 2000). While the NPC 
provides the structure, two major adjacent components govern this process: the transport 
receptors and the Ran system.  
-Transport receptors. It has been well established that certain proteins can interact with FG-
repeats containing Nups and cross the NPC barrier. Among them are the transport receptors of 
the Importin β and NTF2-like families that account for most of the transport events in the cell. 
They also present an affinity for their binding partners or cargoes which permit their 
translocation through the NPC. Based on the direction of transport, the mammalian Importin β 
family members can be subdivided into importins and exportins depending on whether they 
mediate import into or export out of the nucleus (Allen et al., 2001; Arts et al., 1998; Bayliss et 
al., 2002; Fornerod et al., 1997; Görlich et al., 1997; Iovine et al., 1995; Mosammaparast and 
Pemberton, 2004; Ribbeck et al., 1998; Shah et al., 1998; Strawn et al., 2001).  
-The Ran system. Ran is a small GTP switch that is mainly maintained in its GTP form in the 
nucleus and in its GDP form in the cytoplasm. This is achieved by the action of the other 
components of the Ran system: the chromatin bound Ran exchange factor RCC1 and the 
cytoplasmic RanGTP hydrolysis stimulators RanGAP and RanBP1/2. This system modulates 
 
Figure 3. Schematic representation of an import (left) and export (right) cycle. (See full-colour export cycle in 
cover and animation near page number) 
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the affinity of most transport receptors for their cargoes defining the directionality of transport 
and the accumulation of cargos at one side of the NPC (Görlich et al., 1996; Görlich et al., 
1996; Izaurralde et al., 1997; Kalab et al., 2002).  
 
Elements destined to be imported contain nuclear targeting signals which bind with high 
affinity to their import receptors in the cytoplasm (Figure 3). This affinity drops in the nuclear 
environment where RanGTP levels are high. Export receptors in turn require RanGTP to bind 
the cargos that need to be exported through the cytoplasmic targeting signals. This trimeric 
complex is unstable upon translocation to the cytoplasm where RanGTP hydrolysis occurs. 
Released RanGDP is recycled to the nucleus by NTF2 (Gerace, 1995; Kutay et al., 1997; 
Lounsbury and Macara, 1997; Nakielny et al., 1999; Ribbeck et al., 1998; Schlenstedt et al., 
1997). 
 
4.1. Targeting signals 
 
As it is for transport receptors, the variability of targeting signals present in cargos is a 
symptom of the diversity of transport pathways adopted by the cell. The best characterized 
nuclear targeting signals are denominated Nuclear Localization Signals (NLS) and they can be 
simple or bipartite like those of SV40 large T antigen (SV40 TAg) and nucleoplasmin 
respectively. Simple NLS are short sequences containing a single cluster of basic amino acids, 
often preceded by an acidic amino acid or a proline residue. Bipartite NLS are two 
interdependent clusters of basic amino acids separated by a flexible spacer. Neutral and acidic 
residues flanking the motif can contribute too (Kalderon et al., 1984; Makkerh et al., 1996; 
Robbins et al., 1991). The actual NLS receptor is Importin-α which, acting as an adapter, 
promotes formation of an Importinα/Importinβ heterodimer and translocation of the complex 
(Görlich et al., 1995).  
Nuclear Export Signals (NES) are present in a broad range of substrates. They conform more 
or less to the consensus Φ-x2–3-Φ-x2–3-Φ-x-Φ (Φ= L,I,V,F,M; x is any amino acid) and are all 
translocated to the cytoplasm via the export receptor CRM1 (Fornerod et al., 1997; Kutay and 
Guttinger, 2005). In contrast to the case of NLSs and Importinα or other exportin-cargo 
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complexes, the affinity of CRM1-RanGTP complex for the NESs is weak (Askjaer et al., 1999; 
Paraskeva et al., 1999). The biological rationale of this phenomenon has remained unknown.  
 
4.2. RanGTP independent transport. Messenger RNPs  
 
Interestingly, not every transport event follows this general model. As mentioned, other 
proteins that do not belong to the Importin-β family of transport receptors can directly interact 
with the FG-repeats of the NPC promoting passage of themselves or their cargos (Asally and 
Yoneda, 2005; Hetzer and Mattaj, 2000; Vinkemeier, 2004). β-catenin shuttles in and out of 
the NPC by itself in a RanGTP independent manner (Fagotto et al., 1998; Hendriksen et al., 
2005; Yokoya et al., 1999). It has been shown that Importin-α and Importin-β can cross the 
NPC independently in both Ran dependent and independent manners and, irrespective of that, 
RanGTP hydrolysis is not required (Kose et al., 1999; Miyamoto et al., 2002). 
Another case that requires special study is the export of messenger ribonucleoproteins 
(mRNPs). Three key components conserved in eukaryotes and unrelated to the Importin β 
family are recruited to the nascent mRNA: TAP/NXF1 mRNA export receptor (named in yeast 
Mex67p:Mtr2p), DECD or DEAD-box putative RNA helicases and RNA-binding adaptor 
proteins like the hnRNP-like ALY(REF1) (named in yeast Yra1p) or the SR proteins. 
Translocation of the assembled RNP is independent of RanGTP transport and gradient (Huang 
et al., 2003; Huang and Steitz, 2001; Izaurralde, 2004; Reed and Hurt, 2002; Stutz and 
Izaurralde, 2003). In fact, it appears that the mRNA export receptor affinities are regulated by 
cycles of phosphorylation and dephosphorylation on the adaptor proteins (Gilbert and Guthrie, 
2004) 
 
4.3. Transport of ribosomal RNPs 
 
Ribosomes are large RNA and protein complexes and their synthesis implicates the sequential 
coordination of many proteins and snoRNAs (Fatica and Tollervey, 2002). Several import 
pathways participate cooperatively for the recruitment of all the components to the nucleoli. 
With some exceptions (Plafker and Macara, 2002), most of the ribosomal proteins can be 
imported by either of the transport receptors Importin β, transportin, RanBP5 or RanBP7 (Jakel 
Page 23 
Chapter 2 
and Görlich, 1998). In the case of snoRNAs, three different import pathways have been 
distinguished (Michaud and Goldfarb, 1992) and some of these factors involved in RNA 
metabolism shuttle between the nucleus and the cytoplasm, suggesting that they play a 
regulatory role in the maturation process (Leary et al., 2004).  
During the last maturation steps, factors implicated in preribosome release and export 
incorporate to the nucleoli. Ribosomal RNPs are exported via the CRM1 pathway as 
independent subunits (Andersen et al., 2005). Preribosomes are among the largest cargos 
crossing the NPC and their export, which is the principal activity of the NPC, requires the 
action of adaptor proteins and specific mediators. The 60S large subunit utilizes the adaptor 
protein NMD3, that bridges the interaction with CRM1 providing a NES in trans (Ho et al., 
2000; Thomas and Kutay, 2003; Trotta et al., 2003; Warner, 2001). Recent evidence shows that 
the yeast GTPases Nog1p and Lsg1p regulate the interaction of NMD3 with the rRNP at the 
nucleus and cytoplasm respectively (Hedges et al., 2005; Kallstrom et al., 2003). Intriguingly, 
some nucleoporin mutant yeast strains were found to have defective nuclear export of 
preribosomes while ribosomal maturation is not affected (Gleizes et al., 2001). This finding 
suggests a fundamental difference between preribosome export and other transport pathways 
but experimental evidence is lacking.  
 
5. Models of Nuclear Translocation. 
 
The main paradox of nuclear translocation is that inert molecules bigger than ~40 kDa are not 
able to cross the NPC indicating that translocation is a size-dependent diffusion event. 
However, cargo-receptor complexes of 100 kDa have been shown to diffuse through the pore 
at rates comparable to cytoplasmic diffusion (Ribbeck and Görlich, 2001). Furthermore, the 
large 60S ribosomal subunit, whose size is 25nm, is efficiently exported. Integrating all 
experimental evidence to formulate a unique general model of transport seems an arduous task, 
especially when NPC translocation is able to accommodate a broad range of shuttling elements 
with very different properties. Traditionally, three models which contribute to a broad concept 




- Affinity gradient model (Ben-Efraim and Gerace, 2001). It is based on the findings that 
transport receptors bind with variable affinities to different FG-containing Nups and that there 
are some Nups that locate exclusively at either the nuclear or the cytoplasmic side of the NPC. 
It postulates that transport complexes bind to nucleoporins with progressively increasing 
affinity though the translocation route.  
 
- Virtual gating model (Rout et al., 2003). It considers the NPC structure as a channel which all 
molecules encounter but not all can access and NPC translocation as an enzymatic event which 
can be catalysed by the NPC. Selectivity is accomplished by the Brownian action of the FG-
repeats which create a barrier that makes diffusion a thermodynamically complex event. The 
translocation reaction is then favoured by shuttle interactions with the FG-repeats themselves 
or by removing the products of the enzymatic reaction which is achieved by the accessory 
components of the transport machinery. 
 
- Hydrophobic exclusion model (Ribbeck and Görlich, 2002). This model integrates the 
kinetics of nuclear transport and the NPC structure. It considers the FG-repeats as unstructured 
domains that can form a hydrophobic meshwork through weak interactions and the transport 
receptors as the “melting” elements with high surface hydrophobicity. The NPC would not be 
then a rigid channel but a flexible solution that can adapt to the translocating elements. 
 
The main difficulty with the affinity gradient model is how to explain the directionality of 
transport and the fact that it can be reversed (Nachury and Weis, 1999; Yang et al., 2004). In 
fact, some studies excluded that directionality can be driven by differential transport complex-
nucleoporin affinities (Becskei and Mattaj, 2003). Nevertheless, the possible biological role of 
these differential affinities should not be ignored (Fornerod et al., 1997; Kehlenbach et al., 
1999; Rexach and Blobel, 1995; Shah et al., 1998). As an alternative, a role of escort during 
translocation was proposed for the asymmetrically located FG domains of Nup153 and Nup214 
which bind with high affinity to transport receptors (Fahrenkrog et al., 2002; Paulillo et al., 
2005). Although the physical length, localisation and unstructured nature of FG domains make 
this model feasible, recent experimental evidence points to another direction: First, imaging of 
single molecule translocation through the NPC localized the central pore as the location where 
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kinetically important interactions take place. It shows shuttling a rather random movement not 
compatible with an escorted transport (Yang et al., 2004). Second, FG-domain absences on 
asymmetric nucleoporins do not affect receptor-mediated nuclear transport in yeast (Strawn et 
al., 2004; Zeitler and Weis, 2004). This finding argues again against an affinity gradient model 
that would consider FG-domains of asymmetric Nups the most relevant with highest affinities; 
and against a virtual gating model as well that postulates that these domains play an essential 
role in creating the selective barrier. Not only asymmetric FG-repeats but up to 50% of the FG 
mass can be dispensable keeping NPC exclusion diameter and transport unaffected. Except for 
a minimum central FG-region that remains still required, the importance of most FG-repeats on 
NPC function is under debate (Strawn et al., 2004). Nevertheless, some specific transport 
pathways, like mRNPs or rRNPs export, show dependency on the presence of specific Nups, 
indicating that they do not have redundant functions (Fornerod et al., 1997; Gleizes et al., 
2001; Nehrbass et al., 1993). 
 
Very recently, mathematical modeling has shown to be an interesting approach to define 
nuclear transport in a quantitative manner (Becskei and Mattaj, 2005). They are based on the 
fact that nuclear translocation can be compared to translocation of solutes across polymers, 
lipid membranes or protein channels and, therefore, similar mathematical formulations can be 
applied. Three major classes of quantitative models can be formulated: partitioning, NPC 
gating and enhanced diffusion. The partitioning model is equivalent to the hydrophobic 
exclusion model and related to the virtual gating model. It assumes that entering the NPC 
follows equal dynamics as that of permeation of solutes through lipid membranes (Oren et al., 
2004; VanDongen, 2004). The NPC channel, containing FG-domains, would behave as a 
hydrophobic medium (Allen et al., 2001; Bayliss et al., 2002; Buss et al., 1994; Denning et al., 
2001). This model is supported by extensive experimental evidence (Bayliss et al., 2002; 
Bayliss et al., 1999; Smith et al., 2002). NPC gating and enhanced diffusion are variants that 
incorporate the capability of the NPC to modify its properties and therefore its permeability by 
conformational changes that alter the NPC structure (NPC gating) or the shuttle domain 
interactions within the meshwork (enhanced diffusion). No experimental data has shown to 
date the capability of the NPC to enhance the diffusion of a complex while it is translocated. In 
contrast, several studies have shown structural changes that alter the permeability of the NPC 
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(Jaggi et al., 2003; Shulga and Goldfarb, 2003). Furthermore, EM studies have revealed 
conformational states of the NPC associated to transport events that may be representative of a 
functional gating mechanism (Beck et al., 2004; Kiseleva et al., 1998; Stoffler et al., 2003). 
In conclusion, it seems that different nucleocytoplasmic transport mechanisms are compatible 
at the NPC to accommodate passage of many different elements through a unique structure. 
The mechanism of transport that governs for every shuttling molecule is not only dependent on 
its own physical properties, which defines its capability to integrate and move through the 
NPC, but also on the ability of interacting with transport receptors and/or the NPC itself, which 
provokes the NPC properties to suit the efficient transport of this molecule. 
 
6. Dissecting the NPC 
 
Several approaches have been used to study the functional role of individual Nups or 
subcomplexes. In yeast, powerful genetics have implicated specific Nups in transport 
pathways, NPC structure or NE and intranuclear organization (Fabre and Hurt, 1997; Galy et 
al., 2000; Wente, 2000). In contrast, genetic depletion methods in vertebrates are rarely used 
due to the essential nature of the NPC components (Smitherman et al., 2000; van-Deursen et 
al., 1996; Wu et al., 2001). As an alternative to study vertebrate NPCs, Xenopus egg extracts 
are used to promote in vitro NE assembly on chromatin templates. These extracts can be 
submitted to biochemical depletion of single components revealing their relevance in NPC 
assembly or transport pathways (Finlay and Forbes, 1990; Grandi et al., 1997; Powers et al., 
1995; Walther et al., 2003; Walther et al., 2001; Walther et al., 2002). 
The outcome of RNA interference technology (RNAi) (Fire, 1999) and its implementation in 
mammalian cells (Brummelkamp et al., 2002; Elbashir et al., 2001) offers new possibilities for 
the study of individual components of the transport machinery. RNAi studies combined with 
immunolocalisation analysis were used to study Nup93, Nup96, Nup98, Nup107, Nup153, 
Nup205 and the nuclear basket component Tpr (Hase and Cordes, 2003; Krull et al., 2004). 
Salina and co-workers found using RNAi against Nup358 that it is required for kinetocore 
function and therefore identified a NPC component as a link between NE breakdown and 
kinetochore maturation and function (Salina et al., 2003). But to date, none of these studies 
have revealed functional roles of mammalian Nups on specific transport pathways.  
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6.1. The putative oncogene Nup214/CAN. 
 
Frequent breakpoints on chromosome 9 in leukemia associated chromosomal translocations 
raised the interest of the scientific community (Hagemeijer et al., 1990; Kurzrock et al., 1988). 
Such translocations lead to the aberrant expression of proto-oncogenes or fusion proteins with 
oncogenic properties, like the well characterized Philadelphia translocation, typically found in 
Chronic Myeloid Leukemia (CML) and precursor B-cell Acute Lymphoblastic Leukemia (B-
ALL), that produces the fusion of bcr and c-abl genes (De Klein et al., 1986; De Klein et al., 
1982). In the early 90’s, studies performed on the specific chromosomal translocation 
(6;9)(p23;q34) of a defined subtype of acute myeloid leukemia (AML) detected and 
characterized a gene which, due to its proximity to c-abl, was originally designated Cain or 
can. More translocations were found that implicated this gene in leukemogenesis and therefore 
the product of this gene, the protein CAN, was proposed to be a putative oncogene (von 
Lindern et al., 1992; von Lindern et al., 1990; von Lindern et al., 1992). CAN was found to 
belong to the family of Nucleoporins and was then re-baptized Nup214 (Fornerod et al., 1995; 
Kraemer et al., 1994). Interestingly, other oncogenic fusions were shown with the nucleoporin 
gene NUP98 (Ahuja et al., 1999; Arai et al., 1997; Borrow et al., 1996; Hussey et al., 1999; 
Nakamura et al., 1996). These data suggest that nucleoporins play an important role in human 
myeloid leukemia. Kasper and co-workers found that FG-repeats acted as activators of gene 
transcription by interacting functionally and physically with the transcriptional coactivators 
CREB binding protein (CBP) and p300. Considering that FG repeats from different Nups 
elicited similar responses, they proposed that this mechanism may be shared in the 
pathogenesis of leukemias (Kasper et al., 1999). The possible role of FG-domains in 
transcription activation remains to be elucidated. 
Very recently, a novel mechanism for activation of tyrosine kinases in cancer was found in 
Acute Lymphoblastic Leukemia (ALL): the formation of episomes resulting in a fusion 
between NUP214 and ABL1 (Graux et al., 2004). As a consequence, a constitutively 
phosphorylated tyrosine kinase NUP214-ABL1 is overexpressed. In contrast to previously 
found chromosomal aberrations, NUP214-ABL1 lacks FG repeats. The role of Nup214 in 




6.2. The cytoplasmic side of the NPC. 
 
To date, three nucleoporins have been exclusively localized to the cytoplamic side of the NPC: 
Nup88, Nup214 and Nup358. Genetic depletion of Nup214 in mice causes early embryonic 
death. Embryos showed reduced NLS-mediated protein import, and strong nuclear poly(A) 
RNA accumulation suggesting that Nup214 is crucial for NPC function and survival (van-
Deursen et al., 1996). Nup214 contains a carboxy-terminal FG-repeat domain that binds the 
export receptor CRM1 and two central coiled coils domains that associate and Nup88 and 
target Nup214 to the NE (Fornerod et al., 1996; Fornerod et al., 1997). In fact, Nup214 and 
Nup88 form a stable subcomplex and require each other to localise to the NPC (Bastos et al., 
1997; Matsuoka et al., 1999).  
Very little is known about the localization and function of Nup88. It was shown to interact with 
Nup98, a Nup implicated in RNA transport found to shuttle between the nucleus and the NPC 
(Griffis et al., 2002). Mutants of the Drosophila homologue mbo show nuclear accumulation of 
specific proteins due to a defect on the CRM1 export pathway (Roth et al., 2003; Uv et al., 
2000). Some studies associate overexpression of Nup88 with aggressiveness in tumors (Agudo 
et al., 2004). A third Nup214 co-precipitating band of ~66 kDa was detected that may 
correspond to Nup62 based on the interactions described in their yeast homologues (Bailer et 
al., 2000; Belgareh et al., 1998). Nup358, also denominated RanBP2, has no yeast homologue 
and is the biggest Nup (Wu et al., 1995; Yokoyama et al., 1995). It contains FG-repeats, four 
RanBP1-like RanGTP binding domains that can indeed act as RanGTPase coactivators 
(Beddow et al., 1995; Bischoff et al., 1995; Richards et al., 1995; Villa Braslavsky et al., 
2000), and two Zinc-finger domains that bind RanGDP (Yaseen and Blobel, 1999). It has been 
shown that Nup358 can interact with the Importin β receptor (Delphin et al., 1997). These data 
suggest that Nup358 plays a role in nuclear import (Yaseen and Blobel, 1999). The localization 
and possible role in import of Nup214 and Nup358 was assayed using in vitro NE assembly 
and immuno-EM, Nup358 was found to be the major component of the cytoplasmic fibrils of 
the NPC while Nup214 is located near the cytoplasmic coaxial ring. Interestingly in vitro 
assembled NPCs deficient in both Nups were still capable of mediating import of proteins 




7. Molecular dissection of the nuclear pore complex in relation to nuclear 
export pathways 
 
Several findings presented in this thesis have contributed to the current knowledge of the 
biology of the Nuclear Pore Complex. Structurally, the hierarchy towards incorporation to the 
NPC of the cytoplasmic components Nup88, Nup214 and Nup358 and their relevance to 
nuclear transport has been established. Concerning nuclear transport itself, a supporting role in 
CRM1-mediated export has been assigned to Nup358 and an explanation to the weak nature of 
the interaction of CRM1 and its NES-containing cargoes has been elucidated.  
This work has amplified as well the concept of nuclear translocation by creating a distinction in 
transport pathways that, instead of been exclusively dependent on the receptor-NPC and the 
receptor-cargo interactions, consider the characteristics of the cargo itself. In fact, while 
showing cargos that can be exported by CRM1 independently of Nup214, we present first in 
vivo evidence of the implication of Nup214 in a NPC gating mechanism for the CRM1-
dependent export of preribosomes. Furthermore, this result excludes any implication of the 
strong CRM1 binding Nup214 FG-domain in this mechanism and in other suggested models of 
CRM1 export. 
Finally, this thesis has provided information concerning the localization and stability of the 
aberrant product NUP214-ABL that may be of great value for the development of alternative 
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Nuclear pore complexes (NPCs) punctate the nuclear envelope (NE), providing a channel through 
which nucleocytoplasmic transport occurs. Nup358/RanBP2, Nup214/CAN and Nup88 are 
components of the cytoplasmic face of the NPC. Here we show that Nup88 localises midway 
between Nup358 and Nup214 and physically interacts with them. RNA interference (RNAi) of 
either Nup88 or Nup214 in human cells caused a strong reduction of Nup358 at the NE. Nup88 
and Nup214 showed an interdependence at the NPC and were not affected by the absence of 
Nup358. These data indicate that Nup88 and Nup214 mediate the attachment of Nup358 to the 
NPC. We show that localisation of the export receptor CRM1 at the cytoplasmic face of the NE is 
Nup358-dependent, and represents its empty state. Also, removal of Nup358 causes a distinct 
reduction in NES-dependent nuclear export. We propose that Nup358 provides both a platform 
for rapid disassembly of CRM1 export complexes and a binding site for empty CRM1 recycling 





The nucleus is the defining feature of a eukaryotic 
cell, and is surrounded by a double membrane 
known as the nuclear envelope (NE), which 
prevents free diffusion of macromolecules 
between the nucleus and the cytoplasm. NPCs are 
protein channels residing in the NE, through 
which the active and highly specific transport of 
RNA and protein between the nucleus and the 
cytoplasm occurs, a process known as 
nucleocytoplasmic transport (24, 53, 64). The 
NPC is a modular and complex structure, 
displaying 8-fold rotational symmetry (10, 49). It 
is composed of a series of concentric rings at the 
plane of the NE, with 80-100 nm filaments 
extending into the nucleus, distally connected to 
form a basket structure, and ~50 nm filaments 
extending into the cytoplasm (22, 29, 49, 52). 
Approximately 30 proteins termed nucleoporins 
constitute the vertebrate NPC and contribute to 
many of its functions (10). Many nucleoporins 
form subcomplexes, and they collectively afford 
the structural integrity of the NPC, its assembly 
and disassembly during mitosis in higher 
eukaryotes, as well as playing a functional role in 
nucleocytoplasmic transport (59, 64).  
Immuno electron microscopy (EM) 
studies using a variety of techniques and 
antibodies have revealed ultrastructural 
localisations of nucleoporins within the NPC, (e.g. 
(62). These localisations can be used to explain 
how certain substructures of the NPC contribute 
to specific functions. Definitive localisation of 
nucleoporins has been important for developing 
models to explain selective translocation through 
the NPC (8, 50, 53). For example, a subset of 
nucleoporins containing FG-repeats are thought to 
generate a hydrophobic barrier at the NPC, 
permeable only to transport competent 
macromolecules, which suggests they are 
localised at accessible regions of the NPCs, lining 
the translocation route (50, 53). 
Three vertebrate nucleoporins are 
reported to localise exclusively to the cytoplasmic 
face of the NPC, Nup214/CAN, Nup88 and 
Nup358/RanBP2. Nup214 has been localised 
close to the midplane of the NE, possibly as a 
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component of the cytoplasmic ring (33, 63), and 
interacts with Nup88 to form a stable subcomplex 
(6, 20, 40). The mechanism for targeting this 
Nup88-Nup214 subcomplex to the NPC during 
nuclear assembly apparently requires both 
proteins as Nup214 deletion from mouse embryos 
caused mislocalisation of Nup88 from the NPC, 
and the Nup214 interaction domain of Nup88 
expressed in BHK cells mislocalised Nup214 to 
the cytoplasm (6, 18, 20). Nup88 is present at an 
estimated 32 copies/NPC, compared to only 8 
copies of Nup214 (10), and the ultrastructural 
localisation of Nup88 at the NPC is currently 
unknown. Nup358/RanBP2 is localised to the 
cytoplasmic filaments of the NPC (63, 66, 68). 
TEM of purified Nup358/RanBP2 revealed a 
~36nm filamentous structure, and Nup358 
depletion from Xenopus egg extracts caused 
assembly of NPCs lacking detectable cytoplasmic 
filaments, indicating Nup358 as a major, and 
possibly the only nucleoporin constituent of these 
filaments (12, 63). No nucleoporin binding 
partners have been found for Nup358, therefore 
the molecular association of the cytoplasmic 
filaments with the NPC is unknown. Nup88 and 
also Nup214 represent possible candidates, 
although in vitro assembled Nup214-depleted 
NPCs did have cytoplasmic filaments (63).  
Soluble transport receptors are carriers 
that mediate the active transport of 
macromolecules through the NPC (23, 59). 
Biochemical studies have shown that for groups 
of transport substrates there is a specific transport 
receptor that utilises a subset of nucleoporins to 
translocate the NPC (45). Many nucleoporins 
have been shown to bind certain transport 
receptors in vitro, providing primary indication of 
their roles in specific transport pathways. 
However the precise roles of these proteins in vivo 
largely remain to be determined, and in 
vertebrates only a handful of nucleoporins have 
been shown to play dominant roles in specific 
transport pathways using model systems, such as 
in vitro nuclear assembly of Xenopus egg extracts, 
the use of antibodies or overexpression in cultured 
cells and knockout mice (e.g. (5, 57, 62). Nup214 
has been shown to interact with several import 
receptors in vitro (44, 67), however Nup214 
depletion from Xenopus egg extracts resulted in 
assembly of synthetic nuclei still capable of 
nuclear protein import (63), illustrating that 
biochemical evidence is not necessarily indicative 
of an important functional role. With the advent of 
new techniques, including RNA interference, 
more direct functional roles of nucleoporins in 
specific nucleocytoplasmic transport pathways in 
vertebrates can be investigated, as has been 
demonstrated for the role of the Nup107 
nucleoporin subcomplex in NPC assembly (26, 
60). 
Proteins to be exported from the nucleus, 
including transcription factors and certain 
shuttling proteins, carry a short and hydrophobic 
nuclear export signal (NES), which was originally 
discovered in HIV-1 REV and PKI (16, 65). 
CRM1 is the transport receptor that recognises 
NES-containing substrates (1, 19, 21, 47, 55), 
which belongs to a group of export receptors or 
exportins that bind their substrates with RanGTP 
in the nucleus, to form a trimeric export complex 
(3, 19, 30, 36, 37, 56). Like other nuclear 
transport receptors, CRM1 is thought to interact 
directly with specific nucleoporins at the NPC to 
mediate transport. Immunoprecipitation studies 
predict that the most stable interaction of CRM1 
at the NPC is Nup214, and this complex is more 
stable in the presence of RanGTP and NES-
substrate (4, 32). Nup358 has also been identified 
in a complex with CRM1, mediated by the zinc 
finger domains of Nup358 (54), which suggests a 
role in NES-protein export, however more direct 
data supporting an important role in vivo is 
lacking. 
In this study we investigate the 
organisation of the three asymmetrically localised 
cytoplasmic nucleoporins identified in 
vertebtrates, Nup214, Nup88 and Nup358 in vivo, 
to determine the mechanism of assembly of the 
cytoplasmic filaments. Using immuno electron 
microscopy we have localised Nup88 to a position 
separating Nup358 on the cytoplasmic filaments, 
and Nup214 near the cytoplasmic ring, and show 
a novel interaction between Nup88 and Nup358. 
We show that both Nup88 and Nup214 play a 
combined role in anchoring Nup358 to the NPC 
by individually knocking down their in vivo 
expression using RNA interference, and an 
interdependence for their own stability and NPC 
localisation. We also show a functional role for 
Nup358 in CRM1-mediated protein export which 
elaborates and extends earlier biochemical data.  
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Figure 1: Xenopus Nup88 is encoded by two genes and is phosphorylated, and localises adjacent to Nup214/CAN 
and Nup358/RanBP2. (A) Western blot of Xenopus egg extracts probed with anti-XNup88. Asterix represents a 
non-specific cross-reacting band. (B) Immunofluorescence of Xenopus A6 cells probed with anti-XNup88, to 
show specific staining of the NE. (C) A phylogram to show the divergence of the two genes encoding Nup88 in 
Xenopus laevis, and their conservation with respect to human Nup88 and rat Nup84. (D) Western blot of Xenopus 
egg extracts before (-) and after (+) treatment with lambda protein phosphatase (λ-PPase) probed with anti-
XNup88. (E) Representative Scanning electron micrograph (SEM) of an isolated Xenopus oocyte NE labelled 
with anti-XNup88, which was secondary labeled with 10nm colloidal gold. Bar = 50nm (F) Representative 
Transmission Electron Micrograph (TEM) of a 70nm cross-section through an isolated Xenopus oocyte NE 
labeled with anti-XNup88, and secondary labeled with 10nm colloidal gold. N = nucleus, C = cytoplasm. Bar = 
50nm. (G) Summary diagram of the NPC displaying the mean localisation of Nup358, using two separate 
antibodies directed to C-terminal regions of the protein (see (63), Nup88 and Nup214.  Bar = 50 nm. Error bars 




Nup88 is a phosphorylated protein encoded by 
two genes in Xenopus laevis, and is localised 
adjacent to Nup358/RanBP2 and Nup214/CAN  
on the cytoplasmic face of the NPC 
Three vertebrate nucleoporins are known to 
localise mainly to the cytoplasmic face of the 
NPC; Nup214, Nup358 and Nup88. Previous 
studies have determined the ultrastructural 
localisation of Nup214 and Nup358 at the NPC 
(33, 48, 63, 66, 68). In order to investigate the 
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relative organisation of these three nucleoporins, 
we localised Nup88 on isolated Xenopus oocyte 
nuclear envelopes using immuno-gold electron 
microscopy (EM). The sequence of Xenopus 
Nup88 was extracted from EST databases using 
evolutionary conservation to the human and rat 
Nup88 homologues, and a polyclonal antibody 
was raised against a purified recombinant C-
terminal fragment of Xenopus Nup88 comprising 
amino acids 312 to 741. After affinity 
purification, the antibody recognised a pattern of 
three bands at the approximate molecular weight 
of Nup88 on a Western blot of Xenopus egg 
extracts (Fig. 1A). A fourth band was also 
observed, which was subsequently found to be 
non-specific as it was absent when using the 
XNup88 antibody raised in a different animal (not 
shown). To determine the specificity of the anti-
XNup88 antibody in cells, Xenopus A6 cells were 
fixed, permeabilised and immunostained with 
anti-XNup88. A punctate staining of the NE was 
observed (Fig. 1B) characteristic of nucleoporins, 
which overlapped with monoclonal antibody 
(mAb)414 (11), which recognises the FG-repeat 
containing nucleoporins, Nup358, Nup214, 
Nup153 and p62 (data not shown).  
Xenopus laevis is a partially tetraploid 
organism, having duplicated its genome ~30 
million years ago. To determine if the Xenopus 
Nup88 protein is encoded by two divergent genes, 
which would partly explain the multiple banding 
pattern we observe, a more detailed analysis of the 
Xenopus EST database was undertaken. Two 
distinct mRNA species were found, both encoding 
a protein product homologous to human and rat 
Nup88, but only 91% identical to each other, too 
low to be explained by intraspecies variation 
alone. In addition, the 3’ and 5’ UTR sequences 
were more divergent than the coding region, 
which further suggests that Nup88 is encoded by 
two separate genes in Xenopus. The two genes are 
designated XlNup88A and XlNup88B and a 
phylogram shows their evolutionary conservation 
with respect to Human Nup88 and Rat Nup84 
(Fig. 1C). XlNup88A encodes a predicted protein 
product of 726 amino acids, compared to 728 of 
XlNup88B, and the predicted charge of the two 
proteins was strikingly different, -17.8 for 
XlNup88A, and -9.6 for XlNup88B, both of 
which could contribute to a difference in 
electrophoretic mobility.  
Many nucleoporins are phosphorylated 
during mitosis, coinciding with NPC disassembly 
(15, 38, 43, 61) and phosphorylation also affects 
electrophoretic mobility of proteins. To further 
investigate the multiple banding pattern of 
Xenopus Nup88, Xenopus egg extracts were 
incubated with a non-specific protein phosphatase 
from lambda (λ-PPase), before analysis by gel 
electrophoresis and Western blot. The three 
banded pattern of Nup88 was reduced to two 
bands, presumably representing the 
unphosphorylated forms of the two Nup88 
proteins (Fig. 1D). These data suggest that 
Xenopus Nup88 is a phosphorylated nucleoporin 
and is encoded by two highly homologous but 
independent genes. 
The ultrastructural localisation of Nup88 
at the NPC was determined by labelling isolated 
Xenopus oocyte nuclear envelopes with the anti-
XNup88 antibody followed by 10 nm gold-
conjugated secondary antibody. The labelled 
envelopes were visualised using field emission 
scanning EM (FESEM), to image the surface of 
the NE, and transmission EM (TEM) of 70 nm 
cross sections through the NE. Representative 
micrographs from FESEM and TEM are shown in 
Figs. 1E and F. Using FESEM, the localisation of 
the gold particles along a radial axis was 
determined. The mean distance from the centre of 
the NPC was 39 nm ± 17.4 (n=87). Using TEM, 
the gold particles were measured distally from the 
mid-plane of the NE. The mean distance was 30.4 
nm ± 7.6 (n=22). The localisation data is 
summarised in Fig 1G, along with previous 
localisation of Nup358 and Nup214 using the 
same method (63). From these labelling data, 
Nup88 localises, at least in part, to a position in 
between Nup358 and Nup214. 
 
Nup88 is in a complex with both 
Nup358/RanBP2 and Nup214/CAN 
The immunolocalisation studies position Nup88, 
Nup214 and Nup358 in close proximity at the 
cytoplasmic face of the NPC; however only 
Nup214 and Nup88 have been linked 
biochemically and nucleoporin binding partners 









Figure 2: Nup88 is coimmunoprecipitated with both Nup214/CAN, and Nup358/RanBP2. Antibodies to Nup214, 
Nup358, or Protein A Sepharose were incubated with Xenopus egg extract and coimmunoprecipitating proteins 
analysed by labeling a Western blot with anti-Nup358, or anti-XNup88. 
__________________________________________________________________________________________________________________
investigate interaction partners of Nup358 we 
immunoprecipitated Nup358 or Nup214 from 
fractionated Xenopus egg extracts, isolated the 
bound protein complexes using protein-A 
sepharose after extensive washing, and analysed 
the co-immunoprecipitating proteins by gel 
electrophoresis and Western blotting. Nup88 was 
found to specifically coimmunoprecipitate with 
Nup214 (Fig 2, lane 2) as has already been shown 
(6, 17, 18). Interestingly, Nup358 was also able to 
co-immunoprecipitate Nup88 from Xenopus egg 
extracts (Fig 2, lane 3). These data show that both 
Nup214 and Nup358 are interacting partners of 
Nup88, consistent with their ultrastructural 
localisation. 
 
RNA interference of Nup88 and Nup214/CAN 
causes a reduction of Nup358/RanBP2 at the 
nuclear envelope 
Based on immunoelectron microscopy, Nup358 is 
the most distal cytoplasmic nucleoporin from the 
midplane of the nuclear envelope, apparently 
located above Nup88 and Nup214. The 
immunoprecipitation studies predict Nup88 and/or 
Nup214 as the sites of interaction through which 
Nup358 may dock to the NPC. To study the 
organisation of Nup88, Nup358 and Nup214 we 
utilised the technique of small interfering RNAs 
(siRNA, (13) expressed by the pSUPER vector (9) 
to reduce endogenous expression of each 
nucleoporin and analyse the localisation of the 
others using immunofluorescence in human cells. 
Oligonucleotides containing 19 bases from the 
mRNA sequences of Nup358, Nup214 and Nup88 
were cloned into the pSUPER expression vector 
as described in Materials and Methods. The 
pSUPER expression vectors were transfected into 
HeLa or MCF-7 cells by either electroporation or 
lipofection as indicated. Empty pSUPER vector 
was transfected as a negative control in all 
experiments. After 72 hours, double 
immunolabellings were performed and nuclear 
envelope staining intensities of the nucleoporins 




Figure 3: Knockdown of Nup88 or Nup214/CAN causes a decrease in Nup358/RanBP2 at the nuclear envelope 
(NE). Immunofluorescence of HeLa cells after knockdown of Nup88 (B and E), Nup214 (F and H) and Nup358 
(C and I). Cells were fluorescently double-labeled with anti-hNup88 and anti-hNup358F (A, B and C), anti-
hNup88 and anti-CAN9977 (D, E and F) or anti-CAN9977 and anti- Nup358V antibodies (G, H and I). A,D and 
G show control levels 72 hours after transfection with empty pSUPER vector. (J) Graphic representation of the 
results to show fluorescence levels of Nup88, Nup214 and Nup358 after knockdown of each individual 
nucleoporin as a percentage of the negative control. Nup358 analysis was performed using two different 
antibodies leading to similar results.  
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showed clear reduction of the nucleoporin 
targeted by RNAi, and compared to the levels in 
control cells. As shown in Figure 3, antibodies 
against Nup88, Nup214 and Nup358 decorated 
the nuclear envelope in the punctate manner 
characteristic of nucleoporins. Cytoplasmic pools 
of these nucleoporins were also visible at different 
intensities. Nup88 antibodies showed more 
dispersed and higher levels of labelling in the 
cytoplasm than Nup214 or Nup358, whose 
cytoplasmic staining was more discrete and 
concentrated in cytoplasmic bodies (Fig 3, A, D 
and G). Nuclear envelope staining of each of the 
three nucleoporins was significantly reduced after 
transfection with their respective RNAi 
expression plasmids (Fig 3, B1, E1 for Nup88 
RNAi; F2, H1 for Nup214; C2, I2 for Nup358), 
which was verified by gel electrophoresis and 
Western blotting (see Fig 4). Interestingly, 
Nup358 nuclear envelope staining was 
significantly reduced after RNAi of either Nup88 
or Nup214 (Fig 3, B2 and H2 respectively and J). 
Conversely, Nup358 RNAi had no effect on 
Nup88 or Nup214 staining (Fig 3, C1 and I1 
respectively and J), however RNAi of either 
Nup88 or Nup214 provoked significant reduction 
of the other at the NE (Fig 3, E and F respectively, 
and J). These data suggest that Nup88 and 
Nup214 codepend to incorporate into the NPC, 
and Nup358 docking to the NPC in vivo requires 
the presence of both Nup88 and Nup214. 
 
Nup88 RNAi causes an associated decrease in 
the protein levels of Nup214/CAN but not 
Nup358/RanBP2.  
The specific reduction of Nup358 at the NE after 
RNAi of Nup88 or Nup214 could also be the 
result of a decrease in the stability of Nup358 and 
its subsequent degradation. To study the effect of 
nucleoporin RNAi on the protein levels of the 
remaining untargeted nucleoporins, 48, 72 and 96 
hours after transfection cells were lysed directly in 
SDS-sample buffer to minimise breakdown, and 
the proteins analysed by gel electrophoresis and 
Western blotting. Transfection of cells with either 
pSUPER-Nup358 (Fig 4A) or pSUPER-Nup88 
(Fig 4B) results in a clear specific knockdown of 
these proteins within 48 hours, which was stable 
until the last time point tested at 96 hours, 
confirming the decrease observed by 
immunofluorescence. Western blots were also  
_______________________________________________________ 
Figure 4: Efficient knockdown of Nup88 and 
Nup358/RanBP2 using RNAi, and co-reduction of 
Nup214/CAN on knock down of Nup88. (A) Western 
blot of MCF-7 cells transfected by electroporation with 
pSUPER-Nup358 compared to the pSUPER negative 
control collected 48, 72 and 96 hours post-transfection. 
The blot was probed with anti-Nup358, Mab414 and 
anti-CRM1. (B) Western blot of HeLa cells transfected 
by Fugene with pSUPER-Nup88 compared to the 
pSUPER negative control collected 48, 72 and 96 
hours post-transfection. The blot was probed with anti-
Nup358V, anti-hNup88, anti-hNup214, anti-Nup98 
and Mab414. 
_______________________________________________________ 
labelled with other nucleoporin antibodies 
including mAb414. Nup358 RNAi showed no 
decrease in the levels of Nup214 or Nup88 at the 
NE as shown by immunofluorescence (Fig. 3), 
and there was no associated decrease in the 
protein levels of either Nup153 or p62 (Fig. 4A). 
Knockdown of Nup88 however, resulted in a 
significant decrease in the protein levels of 
Nup214 (Fig. 4B), indicating that Nup214 is less 
stable in the absence of Nup88. Importantly there 
was no associated decrease in the protein levels of 
Nup358, indicating that it is the specific 
attachment of Nup358 to the NPC which is 
blocked by Nup88 RNAi and not an effect on 
rotein levels. On knockdown of Nup88 there was 





Figure 5: CRM1 is mislocalised from the cytoplasmic side of the nuclear envelope in Nup358 knocked down 
cells but not when cargo substrate binding is inhibited. HeLa cells were fixed and permeabilised with 0.001% 
digitonin 72 hours post-tranfection with pSUPER (A) or pSUPER-Nup358 (B and C). Antibodies for Nup358, 
CRM1 and DNA were applied. (B and C) Nup358 knocked down cells, indicated by arrows, show reduced CRM1 
nuclear envelope staining at the accessible side of the nuclear envelope. Under these conditions, DNA antibodies 
can only access dividing cells (A3 and B3). CRM1 localisation at the cytoplasmic side of the nuclear envelope 
was not altered on leptomycin B (LMB) treatment of MCF-7 cells (D and F). Treatment was sufficient to abolish 
CRM1 mediated export of a REV-GFP construct (E and G). 
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Nup153 or p62, or indeed Nup98, which has also 
been shown to bind Nup88 in vitro (25). 
 
RNA interference of Nup358/RanBP2 
mislocalises CRM1 
We have shown that Nup358 RNAi specifically 
reduced its own protein levels without affecting 
the protein levels of Nup214, Nup88 or CRM1. 
Immunostaining of CRM1 in mammalian cells 
shows that this transport receptor is highly 
concentrated at the nuclear envelope (1, 20, 34), 
however its binding site(s) are currently unknown, 
and were still present in Nup214 deficient mouse 
blastocysts (20). In order to investigate the 
localisation of CRM1 at the NPC and a possible 
role for Nup358 in export, we immunolabelled 
HeLa cells transfected with either empty pSUPER 
or pSUPER-Nup358. 72 hours after transfection, 
cells were fixed and digitonin permeabilised to 
visualize only the cytoplasmic side of the NE. 
Triple labelling of Nup358, CRM1, and DNA (to 
verify the digitonin treatment) was performed and 
images were obtained using confocal microscopy. 
As shown in Figure 5A, when the NE is intact and 
DNA antibodies are unable to enter the nucleus, 
CRM1 is visible at the cytoplasmic side of the 
nuclear envelope. However after Nup358 RNAi, 
CRM1 accumulation is lost (Fig 5, B2 and 
overexposed C2), clearly indicating that CRM1 
localisation at the cytoplasmic side of the nuclear 
envelope is dependent on Nup358. 
To investigate whether the Nup358-dependent 
localisation of CRM1 at the nuclear periphery 
represented export complexes or empty CRM1, 
we treated MCF-7 cells with 100 nM leptomycin 
B for three hours. Leptomycin B covalently binds 
to CRM1 and dissociates it from RanGTP and 
NES substrates (19, 35, 46). Indeed, leptomycin B 
efficiently blocked CRM1-dependent nuclear 
export as a Rev-GFP-NES substrate accumulated 
in the nucleus (Figure 5G). Under these 
conditions, CRM1 was not reduced at the nuclear 
periphery (Figure 5F). Leptomycin B treatment 
also did not change the reduction of CRM1 upon 
Nup358 depletion (not shown). These data 
indicate that the Nup358-dependent CRM1 
localisation at the nuclear periphery represents 
CRM1 in its empty state. 
 
Nup358/RanBP2 plays a supportive role in 
CRM1-mediated NES-protein export 
_______________________________________________________ 
Figure 6: Nup358/RanBP2 knocked down cells are 
less efficient in CRM1-mediated export of Rev-GFP. 
(A) Rev-GFP transfected MCF-7 cells were scored for 
predominant accumulation of GFP in the cytoplasm 
(nuc < cyto), the nucleus (nuc > cyto), or equal 
distribution (nuc = cyto) between the two 
compartments under control (black bars) or Nup358 
RNAi (white bars) conditions. The mean distribution in 
three independent experiments is shown; error bars 
represent standard errors. Illustrative images of 
Nup358 (C1 and C2) and empty pSUPER control (B1 
and B2) are shown. 
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To determine whether loss of CRM1 from the 
nuclear envelope after Nup358 RNAi is 
functionally significant for CRM1-mediated NES-
protein export, export assays were performed in 
MCF-7 cells by cotransfecting pSUPER with a 
GFP-linked export substrate that includes both the 
NLS and NES of the HIV-1 Rev protein (pRev-
GFP;  (27). Previous studies have shown that 
under normal conditions Rev-GFP partially 
accumulates at the nucleoli, but on treatment of 
cells with actinomycin D the protein is 
specifically exported and accumulates in the 
cytoplasm. The localisation of the export substrate 
was determined 72 hours after transfection using 
confocal microscopy. Cells were cotransfected 
with pRev-GFP and either pSUPER empty vector 
or pSUPER-Nup358. 72 hours after transfection, 
cells were treated with 5 µg/ml actinomycin D for 
3 hours and then fixed and prepared for confocal 
microscopy. Protein export was quantified in three 
independent experiments by counting the number 
of cells (n>100) with predominantly cytoplasmic 
accumulation of GFP, a predominantly nuclear 
accumulation, or an even distribution between the 
nucleus and cytoplasm. Under control conditions, 
Rev-GFP was localised predominantly in the 
cytoplasm in 68% ± 2, consistent with it being 
efficiently exported (Fig. 6A and B1). 22% ± 1 of 
cells had Rev-GFP dispersed evenly between the 
nucleus and cytoplasm, and the remaining 10% ± 
2 of cells showed nuclear accumulation. However, 
after Nup358 RNAi, the localisation of Rev-GFP 
was significantly redistributed towards the 
nucleus (Fig. 6A and C1). 50% ± 5 of cells now 
accumulated Rev-GFP in the cytoplasm, 26% ± 1 
had an even distribution throughout the cell, and 
25% ± 4 accumulated Rev-GFP predominantly in 
the nucleus (Figure 6C1). These results show that 
Nup358 plays a contributory role in CRM1-




We have investigated the organisation of three 
cytoplasmically orientated nucleoporins, Nup358, 
Nup88 and Nup214 at the NPC. Previous studies 
have localised Nup358 and Nup214 to specific 
NPC substructures (33, 48, 63, 66, 68). Here we 
immunolocalise Nup88 and study the role of each 
protein in assembling mature NPCs. We also 
study in detail the function of the cytoplasmic 
filaments in CRM1-mediated nuclear protein 
export.  
 
Characterisation of Xenopus Nup88 
Nup88 was originally identified as an interacting 
partner for Nup214 (6, 20). Here we studied 
Nup88 initially in Xenopus laevis. and found it to 
be encoded by two divergent genes. The two 
genes, designated XlNup88A and XlNup88B, are 
91% homologous, and gene A was found to be 
more abundant in the EST database, indicating 
that it is the more common form. We don't 
currently know which of the two bands identified 
by the antibody on Western blots of 
dephosphorylated Xenopus extracts represents 
which form of Nup88. It is also unclear at present 
whether the two Nup88 forms possess redundant 
functions. Xenopus Nup88 was also found to be 
phosphorylated, which is a common feature for 
many nucleoporins, and is thought to be linked to 
nuclear envelope breakdown and reassembly after 
mitosis (15, 38, 43, 61).  
 
Assembly of the cytoplasmic filaments 
Using a combination of approaches we find that 
the association of Nup358, which is predicted to 
be a predominant component of the cytoplasmic 
filaments from EM structural analysis and studies 
in Xenopus (12, 63), is dependent on interactions 
with and between both Nup214 and Nup88, 
providing evidence of a structural collaboration 
between these three nucleoporins to assemble 
mature NPCs. Firstly we have localised Xenopus 
Nup88 to a position in close proximity to both 
Nup214, a known interacting partner, and 
Nup358, placing it in a position to physically 
interact with the cytoplasmic filaments, possibly 
with the N-terminal leucine-rich domain of 
Nup358 that is suggested to be located at the more 
central position (63). We show that Nup88 can be 
coimmunoprecipitated with both Nup358 and 
Nup214 indicating that the three proteins do 
indeed interact in vivo. It remains possible that the 
Nup88-Nup358 interaction is bridged by 
additional nucleoporins. The levels of Nup88 that 
were co-immunoprecipitated with Nup358 were 
significantly less than with Nup214, however 
Nup214 is known to form a soluble and stable 
subcomplex with Nup88 in the cytoplasm (6, 20), 
and it is possible that the interaction of Nup358 
with Nup88 occurs predominantly at the NPC. To 
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show that the observed interactions and 
ultrastructural organisation of these three proteins 
is relevant to the organisation of the in vivo NPC 
we showed, using an RNAi approach, that the 
association of Nup358 with the NPC was 
specifically dependent on the presence of both 
Nup214 and Nup88. We also found that 
localisation of Nup214 and Nup88 at the NPC 
occurred only in the presence of each other, 
indicating a codependence of NPC localisation. 
This interdependence is consistent with the 
absence of Nup88 in Nup214 knock-out 
blastocysts (58) and a mislocalisation of Nup159, 
the closest yeast homologue of Nup214,  in 
Nup82-∆108 cells, that carry a mutation in the 
yeast homologue of Nup88 (28). 
 We have previously shown that the 
cytoplasmic filaments and Nup358 were still 
present in in vitro synthesised NPCs that lack 
Nup214 (63), again suggesting that it is Nup88 
that makes a physical connection to Nup358 
rather than Nup214. Indeed we were unable to 
detect co-precipitations between Nup214 and 
Nup358.  The precise mechanism of this 
interdependence remains to be elucidated, 
although it may partially be explained by protein 
stability, as reduction of Nup88 caused a 
significant decrease in the protein levels of 
Nup214.  
 
Nup358/RanBP2 and NES-mediated export 
Using an in vivo export assay that was previously 
used to measure differences in nuclear export 
signal strength (27), we found a significant 
decrease in CRM1-mediated nuclear export when 
expression of Nup358 was substantially reduced 
i.e., by 90% or more. In experiments where RNA 
interference was less efficient, hardly any 
reduction in nuclear export could be observed. 
This may explain why RNA interference of 
Nup88 did not affect NES-mediated export, as 
Nup358 levels, even though strongly reduced, 
were not as low.  
Hydrolysis of GTP on Ran is not required for a 
single round of NES-mediated export (14, 51), 
however continued export is predicted to be 
dependent on recycling of both Ran and CRM1. 
In addition, it appears that rapid export complex 
disassembly by RanGTP hydrolysis close to the 
cytoplasmic face of the NPC is required for 
overall export efficiency by enhancing the 
directionality of export (7). Biochemical 
experiments have indicated that CRM1-NES-
RanGTP export complexes bind stably to Nup214 
and are disassembled by the combined action of 
RanGAP and either RanBP1 or RanBP1-like 
domains of Nup358 (4, 32). A main candidate to 
provide these activities is Nup358, as it associates 
with RanGAP, contains RanBP1-like domains and 
is located close to the cytoplasmic exit of the NPC 
(39, 41, 42, 66, 68). The presented results 
showing a decrease in export due to Nup358 
depletion therefore provide direct in vivo support 
of these models. We do not presently have in vivo 
evidence for which is the terminal binding site of 
CRM1 containing export complexes. The strong 
in vitro interaction with Nup214 makes this a 
likely candidate. However, we do not observe 
accumulation of export complexes at the nuclear 
periphery when Nup358 is depleted, suggesting 
that interaction with Nup214 is at least not rate 
limiting. Conversely, we find a strong decrease of 
CRM1 at the nuclear periphery when Nup358 is 
absent. This Nup358-dependent nuclear rim 
localisation does not represent export complexes 
because it is not affected by leptomycin B, which 
is known to dissociate CRM1 from RanGTP and 
cargo (19, 35). Our data therefore indicate that 
Nup358 both provides a platform for rapid 
disassembly of CRM1-export complexes and a 
binding site for empty CRM1 recycling into the 
nucleus. 
 
Materials and Methods 
 
Antibodies 
To generate specific antibodies against Xenopus 
Nup88 (anti-XNup88) a C-terminal fragment 
spanning amino acids 312-741 of the XNup88B  
was expressed as an N-terminal His6-tagged 
fusion protein in pRSET A (Qiagen) in BL21 
(DE3) CodonPlusRIL (Stratagene), isolated from 
inclusion bodies, and dialysed against PBS/8.7% 
glycerol to generate soluble protein. To generate 
antibodies against Human Nup214 (anti-
hNup214), a cross-linked C-terminal peptide 
(amino acids 2076–2090) was synthesised. 
Antibodies were raised in rabbits and affinity 
purified against the antigen crosslinked to an 
Ultralink™ Iodoacetyl gel (Pierce). Anti-
hNup358/RanBP2 antiserum, anti-hNup358V and 
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anti-hNup358F, were generously provided by Dr. 
V. Cordes (Karolinska Institute, Stockholm, 
Sweden), and Drs. A. Gast and F. Melchior (Max 
Planck Institute for Biochemistry, Munich, 
Germany) respectively. Anti-hCRM1 (20), anti-
hNup88 (BD Transduction laboratories), anti-
CAN9977 (Fornerod et al., 1995), monoclonal 
antibody (mAb) 414 (Eurogentec/Babco), anti-
DNA 2C10 antibody, gift from Drs. Yoshiuki 
Kanai and Tetsuo Kubota (University of Tokyo, 
Japan) and anti-hNup98 (31) were previously 
published.  
EM Immunolocalisation 
Nup88 immunolocalisation on isolated Xenopus 
oocyte nuclear envelopes using TEM and FESEM 
was carried out as previously described (62). 
Briefly, antibodies were diluted 1:100 with PBS 
and incubated with isolated Xenopus oocyte NEs. 
The primary antibody was labelled with a 1:20 
dilution of 10nm gold-conjugated anti-rabbit 
secondary antibodies (Amersham) and the 
samples prepared for analysis by FESEM or 
TEM. Negative controls minus primary antibody 
were performed and revealed the secondary 
antibodies to be specific (data not shown). For 
FESEM analysis, isolated NEs were visualised at 
100kx to 300kx magnification and the position of 
gold-labelled antibodies were quantified in 
relation to the centre of the NPC. For TEM 
quantification the distance of the gold particles 
from the midplane of the NE was determined. All 
measurements were calculated using AnalySIS 
software (SIS, Munster, Germany).  
 
Xenopus egg extracts and Immunoprecipitation 
Fractionated Xenopus egg extracts were prepared 
as previously described (62). For 
dephosphorylation of Nup88, 400units Lambda 
protein phosphatase (New England Biolabs) was 
added to 50 µl Xenopus egg extract according to 
the manufacturer’s instructions, and incubated at 
30°C for 15min. For immunoprecipitation, 
extracts were diluted 1:4 in binding buffer (200 
mM NaCl, 20 mM Hepes-KOH, pH7.9, 1 mM β-
mercaptoethanol, Complete Protease Inhibitor 
Cocktail (Roche), 8.7% glycerol) and incubated 
with 4 µg antibody for 1 hour at 4°C. 10µl bed-
volume Protein-A Sepharose beads (Pharmacia 
Biotech) was added and incubated for 1 hour at 
4°C. Beads were collected by centrifugation, 
washed three times in binding buffer, once in 
binding buffer supplemented with 500mM NaCl, 
and eluted in 2% SDS. Samples were mixed with 
SDS protein sample buffer, boiled for 5 minutes 
and analysed by SDS-PAGE and immunoblotting. 
 
Cell Culture 
HeLa cells (ATCC CCL-2) and MCF-7 cells were 
grown in DMEM supplemented with 10%FBS 
(GibcoBRL) and antibiotics, at 37°C and 5% CO2 
in a humidified incubator. Xenopus A6 Cells were 
cultured in L-15 (LEIBOVITZ) medium with 
Glutamax-1 W/ L-amino acids (Gibco) 
supplemented with antibiotics, at 20°C in a 
humidified incubator. 
 
RNA interference of Nucleoporins 
The oligonucleotides used for silencing of Nup88 
(TGCTTTGTTGAACACATCC), Nup214 
(TTGCCCAAGGAACGCTCGA) and Nup358 
(CGAGGTCAATGGCAAACTA), were 
purchased from Sigma (UK), and cloned into the 
pSUPER vector as previously described (9). 
Empty pSUPER vector was used as a control. 
MCF-7 cells or low passage HeLa cells were 
transfected at an estimated efficiency of 50-95%, 
with either 3-4µg pSUPER plasmid using 
electroporation as described previously (2) or 2 
µg pSUPER plasmid in 6 cm dishes using 
Fugene-6 (Roche) according to the manufacturers 
instructions. 48, 72 and 96 hours post-
transfection, cells were either fixed for 
immunofluorescence or lysed directly in boiling 
SDS-sample buffer, and knockdown efficiency 
was analysed by SDS-PAGE and Western 
blotting. Nuclear export assay using pRev-GFP 
was performed as described (27), except that 240 
ng of plasmid DNA was electroporated along with 
4 µg of pSUPER plasmid and expression was 
allowed to proceed up to 72 hours.  
Immunofluorescence Microscopy and Image 
Analysis  
Cells were fixed for 15 minutes in fresh 3.7% 
formaldehyde and permeabilised with either 
0.001% digitonin for 10 minutes (15 minutes for 
Xenopus cells) at room temperature or 0.2% 
Triton-X100 for 10 minutes at room temperature. 
For immunofluorescence, cells were blocked in 
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blocking buffer (1% skimmed milk in PBS) for 15 
minutes at room temperature and incubated in 
primary antibody diluted in blocking buffer for 3 
hours at room temperature. Cells were washed 3 
times in blocking buffer and incubated in 
fluorescently-conjugated secondary antibody 
(Molecular Probes). For double 
immunolabellings, cells were incubated 
simultaneously in the two antibodies, except for 
Nup88 and Nup214 double immunolabelling 
where cells were incubated for 2 hours in anti-
hNup88 followed by addition for 1 hour of anti-
CAN9977. Cells were washed once in blocking 
buffer and once in PBS, then mounted in 
Vectashield (Vector Laboratories). Images were 
recorded with a Leica TCS SP2 confocal 
microscope. For quantification of 
immunofluorescence at the nuclear envelope 
confocal images were analysed using Image J 
software. Nuclear rim intensity measurements at 
four points per cell were averaged and subtracted 
from the intranuclear intensity and intercellular 
background. To exclude possible experimental 
error due to staining variability between samples, 
non-knocked down cells in the same imaged field 
were used as internal controls. 
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Leucine-rich nuclear export signals (NESs) mediate rapid nuclear export of proteins via 
interaction with CRM1. This interaction is stimulated by RanGTP but remains of a relatively low 
affinity. In order to identify strong signals, we screened a 15-mer random peptide library for 
CRM1 binding, both in the presence and absence of RanGTP. Under each condition strikingly 
similar signals were enriched, conforming to the NES consensus sequence. A derivative of an NES 
selected in the absence of RanGTP exhibits very high affinity for CRM1 in vitro and stably binds 
without the requirement of RanGTP. Localisation studies and RNA interference demonstrates 
inefficient CRM1-mediated export and accumulation of CRM1 complexed with the high-affinity 
NES at nucleoporin Nup358. These results provide in vivo evidence for a nuclear export reaction 
intermediate. They suggest that NESs have evolved to maintain low affinity for CRM1 to allow 






Nucleocytoplasmic transport occurs through large 
protein complexes that fenestrate the nuclear 
envelope (NE), termed nuclear pore complexes 
(NPCs) (reviewed in (39, 46, 48). 
Nucleocytoplasmic transport is accomplished by 
soluble transport receptors that interact with both 
cargo and NPC. Importins mediate import of 
several different classes of proteins, while 
exportins mediate nuclear exit of proteins, tRNAs, 
U snRNAs and other RNAs, with the exception of 
mRNAs (reviewed in (19). 
The small GTPase Ran functions as a 
switch that governs directionality of importin and 
exportin-mediated transport (reviewed in (19). 
Nuclear Ran is predominantly bound to GTP, 
whereas cytoplasmic Ran is loaded with GDP. 
Nuclear RanGTP dissociates importin/cargo 
complexes providing direction to nuclear import 
(20). Exportin/cargo heterodimers require the 
cooperative binding of RanGTP as 
RanGTP/exportin/cargo heterotrimeric complexes 
are several orders of magnitude more stable (13, 
26, 27). After translocation through the nuclear 
pore complex, export complexes are destabilised 
by RanBP1 or RanBP1-like domains in 
RanBP2/Nup358. The export reaction is 
completed by hydrolysis of Ran-bound GTP, 
stimulated by RanGAP1 (reviewed in (19).  
One well-characterised example of the 
exportin class is CRM1/exportin1, which exports 
proteins exposing a leucine-rich NES (13, 16, 44). 
Similar to other importin β-like receptors, CRM1 
has been suggested to translocate through the 
NPC by multiple low-affinity hydrophobic 
interactions with FG-repeat containing 
nucleoporins. (38, 39). In addition to these weak 
interactions, the FG repeat region of 
Nup214/CAN, a nucleoporin located at the 
cytoplasmic side of the NPC, forms a particularly 
strong interaction with CRM1, which is further 
stimulated by RanGTP and NES-cargo (2, 14, 24). 
Another nucleoporin that associates with CRM1 is 
Nup358/RanBP2. This protein forms large 
fibrillar structures that emanate from the NPC into 
the cytoplasm (Wu et al., 1995; Yokoyama et al., 
1995; Delphin et al., 1997; Walther et al., 2002). 
CRM1 binds Nup358 in an empty state, which 
suggested that Nup358 serves as docking site for 
recycling CRM1 (3, 42). The majority of 
importins and exportins mediate nuclear transport 
of one or a few structurally related substrates (for 
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examples see (19). Notable exceptions are the 
importin α/β heterodimeric import receptor and 
CRM1, which transport a great variety of proteins 
and ribonucleoprotein particles across the NPC. 
This promiscuity in transport substrates likely 
evolved because these receptors recognise short 
ubiquitous peptide sequences. The leucine-rich 
NES recognised by CRM1 was first identified in 
the viral HIV-1 Rev protein (11) and in the 
cellular protein A phosphorylation inhibitor (PKI) 
(52). Both sequences contain a stretch of 4 
regularly spaced leucines. Numerous studies have 
contributed to the definition of a leucine-rich NES 
consensus sequence as: Φ-X2-3-Φ- X2-3-Φ-X-Φ 
(Φ: L, I, F, V, M; X: any amino acid)(6, 21, 28, 
56). The presence of leucine residues is not a 
prerequisite for NESs and several NESs have been 
identified that diverge from this postulated 
consensus sequence (see (12) for review). 
Following the currently ill-defined NES 
consensus sequence, most proteins are predicted 
to harbour NES consensus sequences. This 
hampers the annotation of valid export signals and 
their characterisation in vivo.  
Although currently characterised NESs 
differ to some extent in their capacity to bind 
CRM1, each possesses a rather low affinity for 
CRM1 (2, 36). This is not characteristic of all 
exportins, as exportin-t and CAS/exportin 2 bind 
their cargo in the low nM range (26, 27). Two 
strong CRM1-interactors have been reported: 
NMD3 and snurportin 1, which bind CRM1 with 
100-fold higher affinity as compared to the well-
studied Rev protein (36, 47). The interaction with 
snurportin 1 is mediated through a large domain 
of at least 159 amino acids, while the domain for 
strong interaction of Nmd3 is unknown.  
In order to select for strong NESs and to 
chart NES diversity, we have screened a 15-mer 
random peptide library for CRM1-binding 
peptides. Surprisingly, both in the presence and 
absence of RanGTP, highly similar sequences 
were selected. In vitro, a derivative of one of these 
NESs bound CRM1 with high affinity, bypassing 
the requirement for RanGTP. In vivo, nuclear 
export of this signal was ineffective, as it 
accumulated at Nup358. We suggest that 
physiological NESs must maintain a low affinity 
for CRM1 to allow efficient disassembly from 
CRM1 and release from Nup358. 
 
 
Figure 1. Selection of CRM1-binding peptides from a 
random peptide library. (A). A phage library displaying 
15-mer random peptides was affinity selected on 
CRM1 columns in the presence or absence of RanGTP. 
The number of selected phages in each recursive 
selection round is expressed as colony forming phages 
selected per million of input. (B). Purified P (P0) and S 
(S0) phages were affinity selected on CRM1 and 
transportin 1 (TRN) columns in the presence or 
absence of RanGTP as indicated. Selected phages were 
compared as above. C. S phages are less responsive to 
RanGTP than P phages. Log ratios of phages selected 
on CRM1 columns in presence (phages+RanGTP) and 
absence (phages-RanGTP) of RanGTP are calculated 




In vitro selection of synthetic NESs  
To identify high-affinity peptide interactors of 
CRM1 we screened a fUSE5 15-mer random 
peptide library (35) with a complexity of 2*108. Z-
tagged CRM1 was immobilised on IgG-sepharose 
columns and affinity selections of 1*109 
infectious phage were performed in the presence 
or absence of RanGTP. To increase selectivity, 
phages selected in the presence of RanGTP were 
eluted through the combined action of RanGAP 
and RanBP1. Three to four selection rounds were 
performed through recursive cycles of phage 
amplification and affinity selection. As shown in 
Figure 1A, clear increases in the number of 
affinity-selected phages were apparent under both 
selection conditions. Sequence analysis revealed 
strong enrichment of a unique signal under each 








Figure 2. Permutations of selected peptides mediate 
distinct CRM1-mediated subcellular localisation. A. 
Amino acid sequences of P0, P1, S0 and S1 15-mer 
peptides compared to the HIV-1 Rev NES and the NES 
consensus sequence. NES sequences are in bold and 
consensus hydrophobic amino acids (φ) are underlined. 
One letter amino acid abbreviations are used. B. 
Shuttling reporter proteins containing GFP, the export 
incompetent Rev(1.4) variant and peptide sequences 
from (A) were transiently expressed in MCF7 cells and 
subcellular localisation was detected by green 
fluorescence 24 hours post transfection. The effect of 
50 nM LMB was monitored 3 hours after addition. C. 
Identification of the critical amino acid residues in S1 
NES. Positions 3 and 8 in P0 and S1 NESs were 
interchanged (left), and subcellular localisation of the 
GFP reporter plasmids were analysed as in (B) (right). 
D. Mutagenesis of the natural RanBP1 NES. A peptide 
corresponding to the natural RanBP1 NES was mutated 
to conform the high affinity NES consensus (left). 
Subcellular localisation was analysed as above (right). 
 
peptide sequence VDLLSSLFSGFSVGG was 
enriched to near-homogeneity after three selection 
rounds in the presence of RanGTP and was 
termed Powerphage or P phage. This phage 
contained the NES consensus sequence 
LSSLFSGFSV, hereafter to be referred to as P0. 
After four selection rounds in the absence of 
RanGTP a single phage was highly enriched, 
termed Starphage or S phage, bearing the 
sequence DVSDLARLFSALGVS. Surprisingly, 
as NES peptides were not expected to bind in the 
absence of RanGTP, this peptide contains an NES 
consensus sequence LARLFSALGV very similar 
to P0 (Fig. 2A). This signal will hereafter be 
referred to as S0. Next, purified P phages and S 
phages were tested individually for their ability to 
specifically bind CRM1 in the absence or 
presence of RanGTP. No binding of either P 
phages or S phages was observed to z-tagged 
transportin 1 columns (Fig. 1B), confirming the 
specificity of the phage display selection. As 
expected, P phages bound CRM1 in the presence 
of RanGTP, and S phages in the absence of 
RanGTP (Fig. 1B). Binding of S phages was 
enhanced 6-fold by RanGTP, compared to a 
stimulation of approximately 250-fold for P 
phages (Fig. 1C). These data suggest that both in 
the presence and absence of RanGTP, leucine-
rich-type NESs were affinity-selected on CRM1 
from a random peptide pool. 
 
In vivo activities of synthetic NESs  
Even though the potential NESs P0 and S0 
conform to the "3-2-1" spacing of hydrophobic 
amino acids, we noted an unusual glycine residue 
between the third and the fourth hydrophobic 
amino acid of the S0 sequence (Fig. 2A). A 
glycine at this position is known to abolish 
activity of the Rev NES (56). We therefore 
mutated this glycine into a serine in S0 and 
replaced in P0 the serine in this position for a 
glycine (Fig. 2A). We named these second-
generation NES sequences S1 and P1, 
respectively. To test the export activities of the 
peptides in vivo, we inserted these into a reporter 
construct that has previously been used to 
compare NES activity (21). This reporter consists 
of green fluorescent protein (GFP) fused to a 
mutant form of the HIV-1 Rev protein, Rev(1.4), 
that provides importin ß-mediated import and 
nucleolar retention but lacks export activity.  
When fused to the strongest NESs, this reporter 
localises completely to the cytoplasm (21). The 
HIV-1 Rev NES sequence was used as a positive 




Figure 3. S1 NES binds to CRM1 with high affinity 
and independent of RanGTP. (A). CRM1 affinities of 
S0 and S1 peptides in recombinant GFP3 fusion 
proteins were measured using the CRM1 RanGAP 
assay, which measures their ability in the presence of 
CRM1 to protect RanGTP from RanGAP-stimulated 
hydrolysis as a function of NES concentration. Regular 
strength NESs of PKI and HIV-1 Rev, and the high-
affinity interaction of 2z-Nmd3 served as references. 
Error bars denote standard errors of three independent 
experiments. (B). Differences in LMB sensitivity of 
export complexes. Different concentrations of LMB 
were added to RanGTP/CRM1 complexes containing 
GFP3-S1, GFP-PKI, the MVM NS2 peptide or 2z-
Nmd3, and stability was measured using the CRM1 
RanGAP assay as above. (C). RanGTP independent 
binding to CRM1 of S1 NES. IgG sepharose columns 
containing 1.5 µM z-tagged CRM1 were incubated in 
the absence (-) or presence (+) of 4.5 µM RanGTP as 
indicated, and in the absence (-) or presence of 1 µM 
GFP3-S1 (S1), GFP3-S0 or GFP3-Rev (Rev). Bound 
fractions are visualised using SDS PAGE and 
Coomassie staining. A fraction of z-tagged CRM1 is 
co-eluted and indicated on the left. 
localise the reporter protein only to the cytoplasm, 
indicating they confer strong export capacities, as 
the export signals completely overcome import 
activity as well as nucleolar retention. P1-GFP 
exhibits faint nucleolar staining similar to the Rev 
control NES. Interestingly, S1-GFP exhibited a 
prominent staining at the NE. This localisation is 
also appreciable for S0-GFP, although to a lesser 
extent. All NES fusion proteins accumulate in the 
nucleus upon treatment with the CRM1 inhibitor 
leptomycin B (LMB) (Fig. 2B). This demonstrates 
that the cytoplasmic localisation mediated by the 
P0, P1, S0 and S1 sequences, as well as the 
nuclear rim staining of S0-GFP and S1-GFP are 
CRM1-dependent.  
 The difference in localisation of the S1 
and P0 NESs could be explained by their 
penultimate hydrophobic position, a critical 
position in Rev-type NESs. To determine if this is 
the case, we mutated this position into leucine in 
P0, creating P2, and into phenylalanine in S1, 
creating S2 (Fig. 2C). When introduced in the 
GFP reporter plasmid and expressed in cells as 
above, P2 mediated a clear nuclear rim staining, 
whereas S2 did not (Fig. 2C). No effect was 
observed when the arginine of S1 was changed to 
serine (S3), or the corresponding serine in P0 was 
changed to arginine (P3) (Fig. 2C). These data 
indicate that the amino acid sequence 
LXXLFXXLSL can mediate CRM1-dependent 
NE localisation. When the hydrophobic residues 
of a naturally occurring NES present in RanBP1 
(57) were mutated conforming this consensus, this 
NES promoted clear nuclear rim localisation (Fig. 
2D). 
 
S1 NES binds to CRM1 with high affinity and 
stably binds without the requirement of 
RanGTP 
In order to understand the striking localisation of 
the S1-like NESs, we analysed the CRM1 binding 
characteristics of this NES in RanGAP and pull-
down assays. We expressed NES peptides as GFP 
fusion proteins in bacteria and purified the 
proteins using affinity chromatography. The 
CRM1 RanGAP assay is based on the fact that 
RanGTP is protected from RanGAP-mediated 
hydrolysis when present in export complexes, and 
can therefore be used to compare NES affinities 






strength, we used GFP fused to the PKI or Rev 
NES (11, 52), whereas the z-tagged form of 
Nmd3 was used as a reference for a high-affinity 
CRM1 interaction in this assay (47). As shown in 
Figure 3A, the protein containing the S1 NES 
showed an approximately 100-fold higher affinity 
for CRM1 than the standard NESs. In fact, the 
affinity of S1 for CRM1 was comparable to the 
2z-Nmd3 protein. The S0 NES showed an affinity 
in between S1 and the standard NESs. To further 
evaluate the affinity of S1 for CRM1, we tested 
the LMB sensitivity of the S1/CRM1/RanGTP 
complex. Increasing concentrations of LMB were 
added to preformed NES/CRM1/RanGTP 
complexes and subjected to RanGAP stimulated 
RanGTP hydrolysis. Under these conditions, 
CRM1 complexes containing the S1 NES were 
resistant to LMB in contrast to standard NESs 
from PKI or MVM NS2 (Fig. 3B). The sensitivity 
of 2z-Nmd3-containing complexes was 
intermediate. When CRM1 was preincubated with 
LMB before addition of the S1 NES, the 
protective effect was lost (Fig. 3B). In this assay, 
the high concentration of RanGAP (100 nM)  
_______________________________________________________ 
Figure 4. S1 NES localises at Nup358. (A). 
Immunoelectron microscopy. Cryosections of MCF-7 
cells transfected with S1-GFP or RevNES-GFP 
containing reporter constructs (see Figure 2) were 
labelled with anti-GFP antibodies followed by protein 
A gold. In cells expressing S1-GFP protein gold 
(arrows) decorates the outer aspect of the nuclear 
envelope at NPCs. (B). Immunofluorescence. Cells as 
in (A), upper panel, were permeabilised with low 
concentrations of digitonin such that the nuclear 
membrane remained intact and labelled with anti-GFP 
antibodies. Anti-GFP antibodies stain the NE and 
colocalise largely with the signal from GFP. (C). 
Knockdown of Nup358 by RNAi removes S1-GFP 
from the NE. HeLa cells were cotransfected with a 
plasmid expressing shRNAs targeting Nup358 or 
Nup214 and a S1-GFP containing reporter plasmid. 
Cells were analysed 72 hours post transfection for 
Nup358 and Nup214 levels and S1-GFP by indirect 
immunofluorescence and direct GFP fluorescence, 
respectively. A strong knock-down of Nup358, but not 
of Nup214 reduces S1-GFP from the NPC. (D). S1 
NES physically interacts with Nup358. Proteins from 
Xenopus interphase egg extracts were affinity selected 
on immobilised biotinylated Rev or S1 NES peptides. 
Starting material (lane 1) as well as bound (lanes 2-5) 
and unbound (lanes 6 and 7) fractions were analysed 





ensures that once RanGTP is released from 
CRM1, RanGTPase is immediately activated 
before RanGTP can rebind to CRM1 (Bischoff 
and Görlich, 1997). Therefore the assay mainly 
measures off-rates, indicating that high affinity 
binding of S1 to CRM1 is accomplished by a slow 
off-rate. 
To assess the capability of S1 to bind CRM1 in 
the absence of RanGTP, a CRM1 pull- down 
assay was performed. CRM1-columns were 
incubated with various GFP-tagged NESs in the 
presence or absence of RanGTP, after which 
eluted fractions were analysed by Coomassie 
staining (Fig. 3C).While binding of S0 and Rev  
_______________________________________________________
Figure 5. S1 NES sequesters CRM1 at the NE (A) and 
in the cytoplasm (B) and can inhibit its own export (C). 
(A). HeLa cells were transfected with the S1-GFP 
containing reporter construct as before and GFP was 
detected together with CRM1 with direct GFP 
fluorescence and indirect immunofluorescence 
respectively. (B). Cells were transfected with the S1 or 
RevNES (Rev) containing GFP reporter plasmids as in 
(A) and nuclear and cytoplasmic CRM1 
immunofluorescence signals were measured in 
confocal sections of 15 transfected (+) or untransfected 
(-) cells. Log ratios of the means are significantly 
reduced in S1-GFP expressing cells, not in RevNES-
GFP expressing cells. Error bars denote standard 
errors. (C). Single cells expressing different levels of 
S0 (black circles), S1 (grey circles) and RevNES 
(white triangles) GFP reporter proteins were analysed 
for nuclear and cytoplasmic GFP levels. S0 NES and 
RevNES mediate cytoplasmic localisation irrespective 
of expresion level. In contrast, the S1 NES promotes 
nuclear export at low expresion levels but not at high 
expression levels. 
_______________________________________________________ 
NES-containing proteins to CRM1 was greatly 
stimulated by RanGTP, GFP3S1 bound both in the 
presence and absence of RanGTP (Fig. 3C). From 
these data, we conclude that the S1 NES exhibits 
a "supraphysiological" affinity (i.e. greater or 
stronger than normally present in the cell) for 
CRM1 such that stable binding to this export 
receptor takes place in the absence of RanGTP. 
 
S1 NES localises at Nup358  
 
To further investigate the prominent NE signal of 
the S1 NES reporter protein, we determined the 
localisation of S1-GFP. Fixed cells were 
permeabilised with digitonin, which permeabilises 
the cell membrane but leaves the NE intact. Anti-
GFP antibodies continued to stain the NE, albeit 
weaker than direct GFP fluorescence (Fig. 4B). In 
cells permeabilised with Triton X-100, allowing 
antibody access to the inside of the NE, the 
nuclear rim staining was the same (data not 
shown) suggesting that antigen accessibility 
explains the difference with direct GFP 
fluorescence. To study S1-GFP localisation at 
higher resolution, S1-GFP and RevNES-GFP 
were localised by immunogold staining on 
ultrathin cryosections using anti-GFP antibodies 
and 10 nm protein A conjugated gold. As shown 
in Figure 4A, S1-GFP predominantly localises to 




the cytoplasmic filaments of the NPC. RevNES-
GFP did not show significant NPC localisation. 
Considering the EM localisation of S1-GFP, we 
selected Nup358 as a candidate for mediating S1- 
GFP accumulation. Short hairpin interfering RNA 
to Nup358 were expressed in HeLa cells together 
with S1-GFP. Cells were analysed 72 h after 
transfection when Nup358 protein levels are  
reduced by up to 90% (3). As illustrated in Figure 
4C, upon knockdown of Nup358, S1-GFP 
disappeared almost completely from the NE. 
Control transfections showed no reduction of 
NPC-associated S1-GFP. Another nucleoporin 
that could mediate S1/CRM1 interaction at the 
cytoplasmic face of the NPC is Nup214 
(Kehlenbach et al., 1999, Askjaer et al., 1999). 
However, removal of Nup214 from the NPC by 
RNAi did not effect S1 localisation (Fig. 4C). To 
confirm that the S1/CRM1 complex physically 
interacts with Nup358, we affinity selected 
proteins from Xenopus interphase egg extract on 
immobilised S1 or Rev NES peptides. In these 
extracts Ran is almost exclusively in the GDP 
bound form. Under these conditions, a significant 
fraction of Nup358 stably associates with CRM1 
to the S1 NES affinity column, not to the Rev 
NES column (Fig. 4D). We conclude that S1 NES 
accumulation at the NPC is directly mediated by 
Nup358. 
 
The S1/CRM1 complex arrests at Nup358 and 
S1 is an inhibitor of CRM1 
We have recently shown that CRM1 localises to 
Nup358 in vivo in a LMB-insensitive way (3) and 
proposed this could represent empty CRM1 
before recycling into the nucleus. Conceivably, S1 
NES attaches to this population of Nup358-bound 
CRM1. Alternatively, the S1-NES/CRM1 
complex could attatch de novo at Nup358. In this 
case additional CRM1, stoichiometric to the S1 
cargo, would be expected to localise at the NE. 
Therefore, we investigated whether CRM1 would 
accumulate with GFP in S1-GFP transfected cells. 
Untransfected cells show a predominantly nuclear 
and NE CRM1 staining (Fig. 5A). Expression of 
S1-GFP at the NE in transfected cells, causes a 
clear NE accumulation of CRM1 (Fig. 5A). To 
assess changes in nucleocytoplasmic distribution 
of CRM1, staining intensities in nuclear and 
cytoplasmic compartments were determined in 
S1-GFP or Rev-GFP expressing cells.  
 
Figure 6. RanGTP can leave the S1/CRM1/RanGTP 
complex at Nup358. (A). GFP3S1/CRM1/RanGTP 
complexes display normal sensitivity to RanBP1. 
Trimeric NES/CRM1/RanGTP complexes were 
assembled and incubated with increasing 
concentrations of recombinant RanBP1, and CRM1 
RanGAP assays were performed as in Figure 3. 
Regular strength NESs of PKI and Rev and the high-
affinity interaction with 2z-Nmd3 served as references. 
anBP1 concentrations of half maximum release of 
protection of GTP hydrolysis (C
R
1/2) are indicated. (B). 
Ran does not accumulate at the NE in S1-GFP 
expressing cells. HeLa cells were transiently 
transfected with the S1-GFP containing reporter 
construct and permeabilised with low concentrations of 
digitonin to ensure intactness of the nuclear membrane. 
S1-GFP and Ran were detected by direct GFP 
fluorescence (left) and indirect immunofluorescence 
(right) respectively. 
_______________________________________________________ 
Transfection of S1-GFP induced a 35% increase 
of cytoplasmic CRM1 (Fig. 5B). CRM1 
localisation was not influenced by expression of 
RevNES-GFP. These data indicate that the 
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S1/CRM1 complex arrests at Nup358 upon NPC 
translocation and that S1 remains bound to CRM1 
in the cytoplasm.  
The sequestering of CRM1 by the S1 NES 
suggests that expression of the S1 could lead to an 
inhibition of CRM1 function. To test this, we 
expressed S0, S1 and Rev-GFP proteins 
transiently for 24 h in MCF-7 cells and measured 
their subcellular localisation as a function of 
cellular protein expression level. As shown in 
Figure 5C, S0 and Rev NESs can promote nuclear 
export of the shuttling GFP reporter, irrespective 
of the expression level. In contrast, S1-GFP only 
promotes cytoplasmic accumulation when 
expressed at low to moderate levels, whereas at 
high expression S1-GFP accumulates in the 
nucleoplasm (Fig. 5C). This indicates that by 
sequestering CRM1, the S1 NES acts as an 
inhibitor of CRM1 function.  
 
S1/CRM1/RanGTP complexes display normal 
sensitivity to RanBP1 
Our data suggest that the S1 NES remains bound 
to Nup358 as a consequence of its ability to bind 
CRM1 without RanGTP. Alternatively, 
S1/CRM1/RanGTP complexes could fail to 
dissociate at Nup358 because they are insensitive 
to RanBP1. In a CRM1 RanGAP assay, low 
concentrations of RanBP1 strongly promote 
RanGTP hydrolysis (2), presumably by loosening 
the RanGTP/CRM1 interaction (4). As shown in 
Figure 6A, all NESs tested in this assay responded 
similarly to RanBP1 addition after export 
complex formation. The RanBP1 concentration at 
which RanGTP hydrolysis has recovered by 50%, 
diverged no more than 3-fold from S1 NES to the 
standard NESs. These data predict that, unlike 
CRM1 (Fig. 5A), Ran does not accumulate at the 
cytoplasmic face of the NPC upon S1-GFP 
expression. To allow visualisation of a potential 
Ran enrichment at the cytoplasmic side of the 
nuclear pore, S1-GFP transfected cells were 
permeabilised with digitonin and stained with an 
anti-Ran antibody. As shown in Figure 6B, Ran 
was not enriched at the NE upon expression of 




In this study, we identify signals exhibiting high-
affinity interactions with the widely-studied 
export receptor CRM1. The results presented here 
bear relevance to the understanding of the 
mechanism of CRM1-mediated export and the 
evolution of leucine-rich NES motifs.  
 
Supraphysiological NESs provide in vivo 
evidence for a novel nuclear export 
intermediate 
An unexpected outcome of our peptide selection 
was that a shuttling substrate containing the 
highest affinity S1 NES accumulated at the NE. 
This accumulation represents CRM1/NES export 
complexes because the localisation is LMB 
sensitive and CRM1 accumulates with the S1 
NES. In addition, immuno-electron microscopy 
showed S1 NES accumulation at the cytoplasmic 
face of the NPC. Since Nup214/CAN binds 
strongly to CRM1 in vitro in a RanGTP and NES 
stimulated way, this nucleoporin represented a 
likely candidate to mediate this NPC localisation 
(2, 15, 24). However, RNAi experiments showed 
that the NE localisation was dependent on 
Nup358. This effectively rules out a potential role 
of Nup214 in the NE accumulation of S1/CRM1 
as Nup214 is not affected by removal of Nup358 
(3).  
A LMB-insensitive interaction between 
CRM1 and Nup358 has been reported in vitro 
(42) and in vivo (3) and most likely represents the 
empty state of CRM1. The S1 NES dependent 
CRM1/Nup358 interaction is cargo dependent and 
LMB sensitive, and must therefore represent a 
different binding site. Co-immunoprecipitation of 
CRM1 with Nup358 from Xenopus egg extracts is 
greatly stimulated by RanQ69LGTP, a non-
hydrolysable form of RanGTP, in contrast to 
importin β, importin 5 or importin 7 (50). This 
observation supports the idea of a cargo-
dependent CRM1 interaction site on Nup358.  
 Why does the high-affinity NES 
accumulate at Nup358, while standard NESs do 
not show this behaviour? Biochemical analyses 
revealed that S1 possesses an affinity for CRM1 
two orders of a magnitude higher than standard 
NESs. Our in vitro data further show that S1, 
unlike standard NESs, is able to interact stably 
with CRM1 in the absence of RanGTP. Thus, a 
likely explanation for the accumulation of S1 at 
Nup358 is that this reflects a failure of the 
S1/CRM1/RanGTP complex to dissociate, thereby 




conformation. Because Nup358 contains four 
RanBP1-like RanGTP binding domains (RBDs) 
the S1/CRM1 accumulation might be bridged by 
RanGTP. However, our biochemical data indicate 
that S1/CRM1/RanGTP complexes are fully 
sensitive to destabilisation by RanBP1. In 
addition, no accumulation of Ran was observed at 
the cytoplasmic face of the NE indicating that Ran 
is able to leave the S1/CRM1/RanGTP complex. 
We conclude that the S1/CRM1 complex remains 
bound to Nup358 via CRM1, mimicking an 
export complex just prior to RanBP1-like RBD 
and RanGAP assisted complex disassembly. As 
illustrated in Figure 7A, we propose that Nup358 
functions as the CRM1 export complex 
disassembly site at the NPC. To facilitate this 
process Nup358 contains binding sites for export 
complexes, RanGTP hydrolysing cofactors as 
well as binding sites for RanGDP and empty 
CRM1. An additional effect of the export 
complex binding site of Nup358 would be to 
decrease reverse export of CRM1 export 
complexes that would form in the cytoplasm. 
Under normal conditions, these complexes are 
unlikely to form because of the cytoplasmic 
activity of RanGAP and RanBP1 (Görlich et al., 
2003; Becsksei and Mattaj, 2003). However, 
under conditions where cytoplasmic RanGTP is 
relatively high, for example by decrease of 
RanGAP activity at lower temperatures (Görlich 
et al., 2003), capture of cytoplasmic export 
complexes may contribute to nuclear exclusion of 
NES proteins. Consistent with this idea, NES 
cargoes and CRM1 accumulate prominently at the 
nuclear rim when added in vitro to permeabilised 
cells in combination with RanQ69L (Kehlenbach 
et al., 1999; (33). Proteins containing NESs such 
as S1 that bind to CRM1 without RanGTP are 
predicted to be more susceptible to reverse export. 
However, S1 is clearly absent from the nuclear 
compartment, indicating that export is more 
efficient than reverse export. This most likely 
reflects the higher affinity of S1 NES for CRM1 
in the nucleus through the cooperative binding of 
RanGTP. We have previously shown that 
reduction of Nup358 leads to a moderate 
reduction of Rev-NES mediated nuclear export 
(Bernad et al., 2004), that we have proposed are 
due to a decrease in CRM1 recycling to the 
nucleus. We have not measured the effect of 
Nup358 depletion on cytoplasmic accumulation of 
 
Figure 7. (A). Model of CRM1 export complex 
disassembly at the cytoplasmic face of the NPC. 
Nup358 is depicted as a filamentous protein (8) with 
the different domains indicated. The orientation is 
suggested by immuno EM studies (51) and the 
localisation of the ALK-Nup358 oncoprotein (30). 1. 
NES/CRM1/RanGTP complexes are translocated 
through the core NPC and bind to a cargo-dependent 
CRM1-binding site on Nup358. This binding may be 
cooperative with RanGTP/Ran Binding Domain (RBD, 
RB1-4) interaction. 2. RanGTP hydrolysis stimulated 
by Nup358-bound RanGAP (31, 32) and the RBDs of 
Nup358 (49, 53, 55). 3. CRM1 can be released into the 
cytoplasm, as is the NES cargo protein (4) or bind to 
the LMB insensitive CRM1 binding site on Nup358 
that is located in the zinc finger region (3, 42); likewise 
RanGDP may bind to the zinc finger Ran Binding 
Domain (54); 5. RanGDP and (6) CRM1 recycle to the 
nucleus. NM, nuclear membranes; Zn, zinc finger 
domains; L-rich, leucine rich domain (See full-colour 
figure in cover). (B). Natural NESs deviate at 
hydrophobic residues from highest affinity NES 
sequence. Alignment of the sequence of previously 
identified natural NESs from MAPKK (17), PKI (52), 
MVM NS2, Xenopus An3 (2) RanBP1 (37) p53 (45) 
and Nmd3 (47) and the artificial P0 and S1 NESs. 
Consensus hydrophobic residues are shaded, 




S1 NES cargoes, but it is conceivable that at low 
expression levels the S1 NES is able to efficiently 
compete for limiting amounts of CRM1, making 
its nuclear export relatively unaffected by Nup358 
depletion. 
 
High-affinity NESs are "too good to be 
optimal" 
We set out to identify signals exhibiting high-
affinity interactions with CRM1 by screening a 
library of 15-mer peptide motifs in a phage 
display setup. The number of representations for a 
random 15-mer peptide encompasses 3*1019 
unique sequences. The complexity of the 15-mer 
peptide library employed was many orders of 
magnitude smaller at 2*108 unique sequences. 
The probability of retrieving a consensus NES, 
defined by 4 hydrophobic amino acids spaced in 
3-2-1, 2-3-1 or 2-2-1 (without intervening 
hydrophobic amino acids) in our library is 
approximately 0.02. Therefore, roughly 4*106 
different consensus NES sequences are expected 
in the library. Remarkably, under RanGTP 
selection conditions, which favoured export 
complex formation, a unique signal was enriched 
after just three rounds. This phage contained the 
highly active P0 NES that conforms to the 
consensus NES sequence. This indicates that the 
phage display selection conditions allowed us to 
enrich high-affinity NESs and that these are rarely 
encountered in the library. In the absence of 
RanGTP, a unique signal was selected, which 
displays a robust NES sequence of a striking 
similarity to the P0 signal. This experimental 
outcome advocates that CRM1 contains one major 
peptide binding site, which corresponds to the 
NES binding site. 
We obtained a quantitative measure of CRM1 
interaction by comparing the S1 NES to a z-
tagged version of Nmd3 (47). This protein 
displays a high affinity for CRM1 comparable to 
that of snurportin 1 (see below). S1-GFP and 2z-
Nmd3 possessed a similar affinity for CRM1 that 
was approximately 100-fold higher than standard 
NESs. Even though a short Rev-type NES has 
been proposed in human Nmd3 that is required for 
CRM1 interaction, this is unlikely to be sufficient 
for the high affinity binding, as the untagged 
version of Nmd3 has a much lower affinity for 
CRM1 (see Thomas and Kutay, 2003 for 
discussion). Interestingly, CRM1 is less sensitive 
to LMB when bound to S1 as compared to 
standard NESs or 2z-Nmd3. LMB covalently 
binds to Cys528 of hCRM1 (25, 34),suggesting that 
access to Cys528 is masked by a tight NES 
interaction.  
In vitro measured affinities between CRM1 and 
NES cargoes are low in comparison to 
interactions of other exportins with their cargo (2, 
26, 27). Snurportin 1, a natural high affinity cargo 
for CRM1, does not contain a short Rev-type NES 
but requires a large domain for CRM1 interaction 
(36). This was taken to suggest that high-affinity 
CRM1 interaction could not be accomplished by 
small leucine-rich type NESs, and that CRM1 
required a co-factor RanBP3 to boost NES-CRM1 
affinity (9, 29). In contrast, our data now 
demonstrate that high-affinity CRM1 binding can 
be accomplished by leucine-rich NESs, but is 
ineffective in vivo, because high-affinity NESs 
interact with CRM1 without RanGTP. As a 
consequence, illustrated by the S1 NES, export 
complexes accumulate at Nup358 and in the 
cytoplasm. This suggests that the large CRM1 
interaction domain of snurportin 1 and perhaps 
Nmd3 are required for efficient release from 
CRM1. Sequence alignment of 58 published high-
confidence NESs display a high level of variation, 
even within the consensus hydrophobic amino 
acids (la Cour et al., 2003). As illustrated in 
Figure 7B, natural NESs only show a subset of the 
hydrophobic residues of the high-affinity NESs. 
When we replaced the consenus hydrophobic 
residues of a natural NES, derived from RanBP1 
protein, into the high-affinity NES hydrophobic 
residues, the mutated version showed high-
affinity behaviour, as it was targeted to the NPC. 
This strengthens the idea that natural Rev-type 
NESs are selected to bind CRM1 but counter-
selected to bind with high affinity. 
In conclusion, selection and analysis of 
high-affinity NES sequences provides clues to 
understanding the low-affinity nature and 
complexity of natural NESs. The highest affinity 
NESs are novel inhibitors of the CRM1 pathway 
and may be useful for structural characterisation 
of the CRM1/NES complex. The approach to 
select supraphysiological cargoes for nuclear 
transport receptors could be more widely 
applicable to study discrete steps of 





Materials and Methods 
 
Antibodies  
Anti-GFP antibodies for immunofluorescence 
were from Abcam, for immunoelectron 
microscopy from Roche. Antibodies to Nup358 
(Walther et al., 2003) CRM1 (14), Nup214 
(Bernad et al., 2004) and Ran (22) were described 
previously. 
Plasmid construction 
For in vivo transport assays, phage inserts were 
provided with BglII and AgeI sites and inserted 
into the AgeI and BamHI sites of Rev(1.4)-GFP 
(21). Second generation mutations were 
introduced by PCR. For bacterial expression three 
copies of GFP were placed in front of the NES, 
and introduced into the XmaI/PstI sites of pQE30 
(Qiagen). pSuper-214, the shRNA expression 
plasmid to Nup214 targets nt 3828-3850 of the 
Nup214 ORF. 
 
Recombinant protein expression and 
purification 
Z-tagged CRM1 and transportin 1 were expressed 
as previously described (2, 18). Ran, RanBP1, 
Rna1p were expressed and purified according to 
Izaurralde et al. (23). Ran was loaded with GTP 
according to the method described previously (5), 
2z-hNMD3 was a gift from U. Kutay (47). NS2 
peptide was described previously (2). GFP3-NESs, 
GFP-PKI (41) and CRM1 (10) were purified on 
Ni-NTA agarose (Qiagen). CRM1 was further 
purified on a Resource Q column. zz-CRM1 and 
zz-transportin columns were prepared as 
published (Askjaer et al., 1999). 
 
Phage display 
The 15-mer phage library (kind gift from T. 
Schumacher) represents a secondary amplification 
of a library initially created by Nishi et al. (35) 
using the filamentous phage vector fUSE5 (40). 
Zz-CRM1 columns were blocked for 2 h at 4˚C in 
phage binding buffer (PBB; TBS, 0.01% Tween 
20, 1 mM MgCl2) containing 1% BSA. After 2 
washes with PBB, 5 µl phage library containing 
1*109 infectious phages were added to CRM1 
columns, either in presence or absence of 4.5 µM 
RanGTP in 50 µl PBB plus 0.1 %BSA. Phages 
were bound for 2 h at 4˚C. Columns were washed 
three times with PBB and eluted for 5 min at RT 
in 50 µl PBB containing 180 nM RanBP1 and 430 
nM Rna1p or PBB alone. Selected phage pools 
were amplified by using E. coli K91-Kan as 
previously described (43). After each selection 
round 0.5 - 1 µl eluted phages and 1 µl of input 
phages were used for titration as described (43). 
After each selection round starting from the 
second round, phages were isolated and amplified 
as described. 0.75µl phage suspension was 
directly used for sequencing, using primer 5’-
TGAATTTTCTGTATGAGG.  
 
CRM1 RanGAP assays 
CRM1 RanGAP assays were performed as 
described (2). For LMB assays, increasing 
concentrations of LMB in 5 µl Ran buffer were 
mixed with 10 µl of 100 nM Rna1 and added to 
assembled complexes containing 1 µM CRM1, 
200 pM Ran[γ-32P]GTP and either 480 nM GFP-
S1, 380 nM 2z-hNMD3, 20 µM PKI-GFP or 5 
µM NS2 present in 35 µl Ran buffer. Pre-
incubation of LMB was performed by addition of 
LMB to 1 µM CRM1 and 200 pM Ran[γ-
32P]GTP, 5 min prior to addition of 480 nM GFP3-
S1. Assays testing RanBP1 sensitivity were 
performed by incubation of export complexes 
containing 360 nM CRM1 and concentrations as 
described for other GAP assays. Increasing 
concentrations of RanBP1 in 5 µl PBS/8.7 % 
glycerol together with 10 µl 100 pM Rna1 in Ran 
buffer were used for Ran[γ-32P]GTP hydrolysis. 
 
Pull down assays 
To detect recombinant CRM1/NES interaction, z-
tagged CRM1 columns were incubated with 1 µM 
GFP-NES protein and 2.5 µM RanGTP when 
indicated. Binding reactions were performed in 50 
mM HEPES-KOH pH 7.9; 200 mM NaCl; 8.7% 
glycerol (buffer B) containing 0.1 mM DTT. After 
slowly shaking for 2 h at 4˚C, beads were washed 
three times with buffer B and eluted for 10 min at 
RT with 50 µl buffer B. Samples were 
fractionated on SDS-polyacrylamide gels and 
visualised by Coomassie staining. To detect 
interaction with Nup358, 0.5 µmol of biotinylated 
S1 or Rev (GVPLQLPPLERLTLDC) NES 
peptide was immobilised on 5 µl streptavidin 
agarose beads (Sigma). NES beads were blocked 
for 1 h in 1% BSA and incubated for 3 h with 100 
µl of Xenopus interphase egg extract diluted 1:1 
with 10 mM HEPES pH 7.4; 100 mM KOAc; 
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3mM MgOAc; 5 mM EGTA; 150 mM sucrose; 1 
mM DTT (acetate buffer). Beads were washed 
three times with acetate buffer and bound proteins 
were eluted in 0.2% and 2% SDS. Bound and 
unbound fractions were separated on 6% SDS-
PAGE and blotted. 
 
Cell culture and transfections 
MCF-7 cells were transfected using 
electroporation as previously described (1). HeLa 
cells were transfected by using Fugene-6 (Roche) 
according to manufacturer’s instructions. Both 
cell lines were transfected with 1 µg of pRev(1.4)-
GFP plasmids on glass coverslips in 35 mm 
diameter dishes. Cells were fixed 24 h post 
transfection. When required, 50 nM LMB was 
added 3 h prior to fixation. For RNAi assays 1 µg 
of pSuper-358 (Bernad et al., 2004) or pSuper-214 
was co-transfected and cells were cultured for 72 
h before analysis. 
 
 Immunofluorescence stainings and image 
analysis 
Indirect immunofluorescence was performed as 
previously described (3). Images were recorded 
with a Leica TCS SP2 confocal microscope. For 
CRM1 localisation analysis Image J software was 
used to measure the nuclear and cytoplasmic 
intensities of 15 cells. For measuring nuclear 
export as function of GFP-NES expression level, 
total cellular and nuclear GFP signals were 
recorded using large pinhole confocal 
microscopy. To cover the complete range of 
expression, fields of cells were recorded with 
different PMT settings (250 to 550 V), and pixel 
values were combined using PMT to pixel value 
calibration curves. 
 
Cryoimmunogold Electron Microscopy 
Transfected MCF-7 cells were fixed, sectioned, 
immunolabeled and imaged as described (7).  
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“Was many years ago that I left home and came this way 
I was a young man, full of hope and dreams 
But now it seems to me that all is lost and nothing gained 
Sometimes things ain't what they seem” 
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The nuclear pore complex (NPC) conducts macromolecular transport to and from the nucleus and 
provides a kinetic/hydrophobic barrier composed of phenylalanine-glycine (FG) repeats. Nuclear 
transport is achieved through permeation of this barrier by transport receptors. The transport receptor 
CRM1 facilitates export of a large variety of cargos. Export of the ribosomal 60S subunit follows this 
pathway through the adaptor protein NMD3. Using RNAi, we depleted two FG-containing cytoplasmic 
oriented NPC complexes, Nup214/Nup88 and Nup358, and investigated CRM1-mediated export. A 
dramatic defect in NMD3-mediated export of preribosomes was found in Nup214/Nup88 depleted cells, 
while only minor export defects were evident in other CRM1 cargos or upon depletion of Nup358. 
Derivatives of Nup214 lacking the FG-repeat domain rescued the NMD3 export defect. We show that 
this domain is not accessible to freely diffusing molecules from the nucleus, indicating that it does not 
conduct cargo through the NPC. The coiled-coil region of Nup214 is sufficient for stabilizing the 
Nup214/Nup88 subcomplex and NMD3 export. We propose that Nup214 plays independent roles in 
NPC function by participating in the kinetic/hydrophobic barrier through its FG-rich domain and by 




Selective communication between the nucleus and 
the cytoplasm in eukaryotes occurs through 
nuclear pore complexes (NPC), multiprotein 
assemblies that transverse the nuclear envelope 
(NE) (1-3). Each NPC is composed of ~30 
proteins, collectively termed nucleoporins (4), and 
displays an 8-fold horizontal rotational symmetry 
in relation to the NE (5). The general shape of the 
NPC is conserved from yeast to humans (4,6,7), 
but individual nucleoporins differ widely in 
sequence. A large subset of nucleoporins contains 
long phenylalanine-glycine dipeptide containing 
domains (FG-repeats) which are thought to form a 
hydrophobic/kinetic meshwork creating a barrier 





 of transport receptor complexes (2,8). These 
complexes are thought to pass the NPC by  
interacting with FG-repeats, thus permeating the 
NPC core (8-11). To achieve nuclear transport, 
proteins and RNAs bind transport-competent 
receptors, either directly or indirectly via adaptor 
proteins (12-16).  
Directionality of transport through the NPC is 
determined by the Ran GTP/GDP gradient which 
exists between the nucleus and the cytoplasm (17-
19) and/or the presence of specific high affinity 
binding sites for transport receptors located at 
either the nuclear or cytoplasmic faces of the NPC 
(20). Although the general NPC architecture is 
symmetric, the localisation of several 
nucleoporins is restricted to either the nuclear or 
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the idea that nucleocytoplasmic asymmetry might 
be established by asymmetric distribution of 
specific binding sites at the NPC. Indeed, 
preferential interactions between several transport 
receptors and specific FG-containing nucleoporins 
have been described in vitro (21-24). In contrast, 
recent studies in yeast show that receptor-
mediated nuclear transport is not affected when 
FG-repeats of asymmetric nucleoporins are absent 
(25,26), indicating that they are not essential for 
directional transport and that the FG-domains of 
different nucleoporins may be functionally 
redundant. Furthermore, imaging of single 
molecule translocation through the NPC shows 
that the most kinetically important interactions 
during nuclear translocation take place in the 
central pore and that these interactions exhibit the 
characteristics of unbiased diffusion indicating 
that there is no directionality within the NPC itself 
(27).  
Next to permeation, gating is a second proposed 
mode of energy-dependent NPC translocation. It 
involves conformational changes of the NPC to 
achieve transport (28) and it is supported by 
conformational states that have been detected 
under various conditions (29-32). The role of 
individual nucleoporins in this process is 
unknown. 
The Nup214/ Nup88 subcomplex is localized to 
the cytoplasmic face of the NPC (33). Nup214 is 
dispensable for in vitro NPC assembly and protein 
import (34) but it is essential in vertebrate cells 
and its depletion causes a strong mRNA export 
defect (35). Nup214 contains two central coiled 
coils known to interact with Nup88 (21,33) and a 
long C-terminal FG-repeat that interacts strongly 
with the transport factor CRM1 in vitro in a 
RanGTP and cargo stimulated fashion (21,36). 
These data suggest that Nup214 plays an essential 
role in CRM1 mediated export. But it remains to 
be elucidated if and how NPC asymmetry 
influences transport processes that are initiated on 
the opposite side of the NPC (37). Recent studies 
proposed that the FG-rich domain of the 
asymmetric nuclear Nup153 and cytoplasmic 
Nup214 can cross the NPC providing a binding 
site to transport receptors and escorting transport 
complexes through the NPC (38,39). 
CRM1 mediates the nuclear export of proteins 
bearing a nuclear export signal (NES) by binding 
cooperatively with RanGTP (13,16,40,41). The 
nature of NES-containing cargos differs widely. 
The large subunit of the ribosome is exported to 
the cytoplasm via the CRM1 pathway, assisted by 
the transport adaptor NMD3 (42-44).  
We have compared the roles of the 
Nup214/Nup88 and Nup358 complexes in 
different CRM1 export pathways. We show that 
the CRM1-mediated export of the 60S ribosomal 
subunit is dependent on the Nup214/Nup88 
subcomplex while that of small NES cargos 
remains relatively unaffected. We show that the 
central domain of Nup214 is required for 60S 
export and Nup88 targeting to the NPC, while the 





anti-hNup358V, and anti-hNup358F were 
generously provided by V. Cordes (Karolinska 
Institute, Stockholm, Sweden), A. Gast and F. 
Melchior (Max Planck Institute for Biochemistry, 
Munich, Germany), respectively. Antibodies to 
Nup214 (45) anti-hNup88 (BD Transduction 
Laboratories), monoclonal antibody (MAb) 414 
(Eurogentec/Babco) and anti-HA (12CA5) were 
previously described. 
 
Plasmid construction−pSuper-358 (45), pSuper-
214, Rev-S1-GFP (24) and HA-Nup153 (46) were 
described previously. The NLS-eGFP-NES insert 
containing the SV40 NLS and PKI NES was 
subcloned from pBSSK (47) into the pcDNA3 
vector (Stratagene) using the HindIII NotI 
restriction sites. The NLS-eGFP insert was 
amplified by PCR from pBSSK using F primer 5’ 
CCCCTCGAGGTCGACGGTATC 3’ and R 
primer containing a NotI site 5’ 
ATATATATAGCGGCCGCTTAGTTTCTAGAC
TTGTACAGCTC 3’ and subcloned into 
pCDNA3 by digestion with HindIII and NotI. 
GFP-NMD3 and rpL29-GFP were a kind gift 
from U. Kutay (43). To create a RNAi insensitive 
Nup214 expressing plasmid, DpnI mediated site-
directed mutagenesis was performed on 
pBluescriptKS(-)CAN (48) creating four silent 
mutations in the target sequence 
TCACATCCGCTAGCAACAC. Wild type and 
mutated Nup214 coding sequences were 
subcloned into the EcoRI sites of pcDNA3 
(Stratagene). A DNA oligo, which contained 
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AgeI, SacII and FseI sites, was cloned into the 
RNAi insensitive Nup214 XcmI sites, located at 
positions 6157 and 6253 of the ORF, leading to 
the parental construct. The AgeI and FseI sites 
were used to perform unidirectional deletions 
using the ExoIII/S1 Deletion Kit (Fermentas). To 
create Nup214-FRB, the FRB domain lacking the 
HA1 tag from the plasmid pC4-RHE (Regulated 
Heterodimerization Kit, Argent) was PCR 
amplified and cloned in-frame into the parental 
construct using AgeI and SacII sites. To create 
pcDNA3 HA-Nup214(585-832), HA-
Nup214(804-1058) and HA-Nup214(585-1058), 
Nup214 regions were PCR amplified on 
pBluescriptKS(-)CAN (48) and cloned into 
pcDNA3-HA (49). FKBP lacking the HA1 tag 
and SV40 NLS was PCR amplified from the 
plasmid pC4EN-F1E (Regulated 
Heterodimerization Kit, Argent) to clone into 
pRev(1.4)-GFP (50) using BamHI and AgeI sites; 
and into GST-NLS-GFP from plamid pEW103 
(kind gift of Erik Wiemer, Erasmus University 
Rotterdam, The Netherlands) using BsrGI and 
SacII sites. All constructs were sequenced for 
confirmation. 
Cell culture and transfections−Low passage HeLa 
cells and MCF-7 cells (ATCC CCL-2) were 
grown in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum 
(GibcoBRL) and antibiotics at 37°C and 5% CO2 
in a humidified incubator. Transfections were 
performed using electroporation on MCF-7 cells 
as described previously (51) or Fugene-6 (Roche) 
on HeLa cells according to the manufacturer’s 
instructions. For all RNAi assays in HeLa cells, 
experiments proceeded for 72 hours and the 
amount of pSUPER plasmids transfected was 
106ng/cm2 on 70-80% confluent cells. pSUPER-
GFP was a generous gift from Rene Bernards, 
NKI Amsterdam. For immunofluorescence 
experiments, NLS-GFP, NLS-GFP-NES and 
GFP-NMD3 were co-transfected at a maximum of 
47ng/cm2, pRev-NES-GFP as described (45), 
pRev-S1-GFP at 21.7ng/cm2, rpL29-GFP at 
1.2ng/cm2, pRev-FKBP-GFP at 1ng/cm2 and 
GST-NLS-GFP-FKBP at 2.3ng/cm2. For all 
rescue experiments pcDNA3 derived plasmids 
were co-transfected at 5.3ng/cm2 except for the 
heterodimerization assays where Nup214-FRB 
was co-transfected at 7.3ng/cm2 maximum. For 
western blot analysis, pcDNA3 and pcDNA3-HA 
derived plasmids were co-transfected at 
26.5ng/cm2. The non-immunosupresive rapalog 
AP21967 (Regulated Heterodimerization Kit, 
Argent) was used at 500nM for 3 h prior to 
fixation except for Nup214 overexpression, which 
was at 250nM. Leptomycin B was used for 2 
hours at a concentration of 100nM. 
Immunofluorescence stainings and image 
analysis−Indirect immunofluorescence was 
performed as previously described (45). Images 
were recorded with Leica TCS NT2 and SP2 
confocal microscopes and analysed using ImageJ 
Software. For subcellular distribution studies, a 
minimum of 100 cells per condition were scored. 
Presence of Nup214 at the NE (Figure 3A, 
Nup214 expression) was defined as positive when 
rim intensities were 3-fold higher than average 
cytoplasmic intensities, determined using Image J 
Software. Nup88 NE staining analysis was 
performed as previously described (45) on 25 
cells per sample. 
 
RESULTS 
The Nup214/Nup88 subcomplex is dispensable for  
basic NES-mediated nuclear export− The strong 
in vitro interaction between Nup214 and CRM1 
(21,36), suggests that this nucleoporin has an 
important role in NES-mediated nuclear export 
(20,36). To test this, we depleted Nup214 by 
expression of Nup214-specific shRNAs in human 
cells and recorded nucleocytoplasmic localisation 
of NES-reporter proteins. To confirm efficient 
depletion, Western blot analyses were performed 
on knocked-down cells lysates. As shown in 
Fig.1E, Nup214-shRNA resulted in strong 
depletion of Nup214 (lane 1), while shRNA 
directed to Nup358 (lane 2) or GFP (lane 3) had 
no effect. As expected from previous studies, 
knockdown of Nup214 caused a strong depletion 
of Nup88, indicating that the stability of these two 
nucleoporins is co-dependent (45). We first tested 
a NES-reporter protein consisting of the NES 
derived from PKI (52) fused to GFP. Import 
activity of this protein is provided by an SV40 
nuclear localization signal (NLS). In control cells, 
this reporter protein is excluded from the nuclei, 
indicating that the NES is active and prevails over 
the NLS activity. Nuclear accumulation of this 
protein was detectable when cells were treated 
with the CRM1 inhibitor Leptomycin B, 






























Figure 1. Wild type levels of the Nup214/Nup88 
subcomplex are not required for basic NES-
mediated nuclear export. Subcellular distribution of 
the NES reporter proteins NLS-GFP-NES (A-C) 
and Rev(1.4)-NES-GFP (D) depleted for 
Nup214/Nup88 (A,C and D) or Nup358 (B,C and 
D) in HeLa and MCF-7. Cells were immunolabelled 
with anti-hNup214 (A2 and A4) and anti-hNup358F 
(B2 and B4) primary antibodies and Texas Red 
labelled secondary antibodies. Scale bars represent 
20µm. (C), (D). Quantification of the subcellular 
distribution of NLS-GFP-NES and Rev(1.4)-NES-
GFP on knocked down cells. 100 fluorescent cells 
per condition were scored for predominantly 
nuclear (Nuc>Cyt), equal (Nuc=Cyt) or 
predominantly cytoplasmic (Nuc<Cyt) GFP 
fluorescence intensity. The mean distribution is 
shown and error bars represent standard errors. (E). 
Western Blot of HeLa cells transfected with pS-
Nup214 (lane 1), pS-Nup358 (lane 2) and pS-GFP 
(lane 3). Blots were probed for Nup358, Nup214, 
Nup153 and Nup88 using anti-Nup358V, anti-
hNup214, MAb 414 and anti-hNup88 respectively. 
Note that knock-down protein levels are an 
underestimate of true knock-down efficiency, due to 
incomplete targeting of the cell population by 
transient transfection, especially noticeable for 
Nup358. 
CRM1 pathway (Figure 1, A3). Energy depletion 
of transfected cells by chilling on ice resulted in 
an even distribution of the protein between the 
nucleus and the cytoplasm, indicating that the 
reporter protein is small enough to slowly diffuse 
through the NPC (data not shown). Surprisingly, 
depletion of the Nup214/Nup88 subcomplex 
caused only a small export defect (Fig. 1A and C). 
Nuclear export of the NES-GFP-NLS reporter in 
cells depleted of Nup358 was unaffected (Fig. 1B 
and C). We have previously shown that depletion 
of Nup358 caused a small reduction in export of a 
Rev(1.4)-GFP-NES reporter protein (45), which is 
targeted to the cytoplasm and sensitive to LMB 
(24,50). In addition to an NLS, the Rev(1.4) 
protein also provides nuclear retention activity 
which permits a more stringent assessment of 
nuclear export. We repeated the above 
experiments using this reporter protein. In this 
case, depletion of either Nup358 or the 
Nup214/Nup88 subcomplex resulted in a 
moderate reduction of export efficiency (Fig. 1D). 
As the Nup214/Nup88 subcomplex is required for 
anchoring of Nup358 to the NPC (45), the  
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reduction of nuclear export by depletion of 
Nup214/Nup88 may be largely attributable to co-
depletion of Nup358 from the NPC. We conclude 
that the Nup214/Nup88 subcomplex does not 
have a major role in NES-dependent nuclear 
export of these cargos. 
Figure 2. The Nup214/Nup88 subcomplex is 
required for CRM1-mediated 60S preribosome 
export. (A), (B). Subcellular distribution of GFP-
NMD3 and RpL29-GFP expressing HeLa cells 72 
hours after co-transfection with pSUPER control 
(A1:2, A7:8 and B1:2) or shRNAs expression 
plasmids targeting Nup214 (A3:4 and A9:10) or 
Nup358 (B3:4). Cells were fluorescently labelled 
with anti-hNup214 (A2, A4, A6, A8 and A10) and 
anti-hNup358F (B2, B4 and B6) primary antibodies 
and Texas Red labeled secondary antibodies. HeLa 
cells expressing GFP-NMD3∆NES represent 
maximum nuclear accumulation (A5, and B5). 
Scale bars, 10µm. (C) Quantification of results 
illustrated in (A) and (B) showing percentages of 
cells presenting nuclear accumulation (Nuc>Cyt) of 
GFP-NMD3, GFP-NMD3∆NES and rpL29-GFP as 
well as those for the supraphysiological NES 
reporter Rev(1.4)GFP-S1. Error bars represent 
standard errors. 
 
The Nup214/Nup88 subcomplex is required for 
CRM1-mediated 60S preribosome export− 
Considering the discrepancy between the strong 
binding in vitro between CRM1 and Nup214 and 
the weak effects of Nup214 depletion on NES-
mediated export in vivo, we hypothesized that 
Nup214 might be required for certain classes of 
CRM1-dependent nuclear export substrates. It has 
been previously shown that the large 60S 
preribosome subunit is exported via CRM1 and 
the transport adaptor NMD3 (43,53). We 
therefore investigated the role of the 
Nup214/Nup88 subcomplex in 60S preribosomal 
nuclear export by studying the localisation of 
GFP-tagged NMD3 (43).  
In control cells, GFP-NMD3 was largely excluded 
from the nucleus (Fig. 2A and C). This 
cytoplasmic localisation of NMD3 was strictly 
dependent on its NES (Fig. 2A and 2C). Depletion 
of the Nup214/Nup88 subcomplex resulted in a 
striking nuclear redistribution of GFP-NMD3 
(Fig. 2A and C). In contrast, Nup358 deficient 
cells showed no difference to the control (Fig. 2B 
and C). The localisation of the NMD3∆NES 
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Figure 3. The FG-repeat domain of Nup214 does not access the nucleus. (A) Schematic representation of a 
system to assess nuclear presence of the FG repeat domain of Nup214. Nucleoporins Nup214-FRB and Nup88 are 
represented as red and orange circles respectively. The dashed red circle around Nup214 represents the minimum 
reach area required of an unstructured Nup214 FG-repeat domain to access the nucleus. After addition of the 
rapamycin dimerizer (purple ovals; A2), nuclear GFP-FKBP (green circles) would accumulate at the NE only if 
the Nup214 C-terminus has access to the nucleus (A3). Cytoplasmic GFP-FKBP would accumulate at the NE if 
the FG repeat domain of Nup214 has access to the cytoplasm (A4). N, nucleus; C, cytoplasm. (B, C and D) 
Subcellular localization of GST-NLS-GFP-FKBP (B, D) or Rev(1.4)-FKBP-GFP (C) after knockdown of 
endogenous Nup214 and exogenous expression of Nup214-FRB. Note that in D1:3 GST-NLS-GFP-FKBP is 
present in nucleus and cytoplasm. Nup214 is detected by anti-hNup214 and Texas Red labelled secondary 
antibody. Rapamycin derived heterodimerizer (AP21967) is added as indicated. Scale bars, 10 µm. (E) FRB-
tagged Nup214 is active in promoting 60S preribosomal export. Rescue of GFP-NMD3 nuclear export in Nup214-
depleted cells by parental (left) or FRB-fused Nup214 proteins. Methods as in Fig. 4. (Full-colour images shown 
in cover flap). 
 
Nup358-shRNA expressing cells, indicating that 
NMD3 nuclear import was not impaired by 
depletion of the Nup214/Nup88 subcomplex or 
Nup358 (data not shown). To confirm that nuclear 
accumulation of GFP-NMD3 reflected a 60S 
preribosome export defect, the localisation of the 
preribosomal component rpL29 was assessed in 
wild-type or Nup214/Nup88 depleted cells. Apart 
from the accumulation at the nucleoli, which is 
also observed in control cells, depletion of 
Nup214/Nup88 resulted in a strong nuclear 
accumulation of GFP-tagged rpL29 (Fig 2A8, 10 
and C). In vitro, certain recombinant versions of 
NMD3 possess a very high affinity for CRM1 
(43), approximately 100-fold higher than regular 
NESs. To test whether the export defect due to 
depletion of Nup214/Nup88 was specific for high 
affinity NESs, we determined the nuclear export 
driven by an NES of a similar affinity, the 
supraphysiological S1 NES (24). Depletion of 
Nup214/Nup88 did not induce nuclear 
accumulation of this reporter protein, indicating 
that the effects were not related to high-affinity 
CRM1 binding of NMD3 (Fig 2C).  
 
The FG-repeat domain of Nup214 cannot access 
the nucleus− It has been proposed recently that 
the FG-domain of Nup214 could access the 
nuclear compartment providing a binding site for 
export complexes. This mechanism would explain 
how a cytoplasmic localised nucleoporin can 
mediate export (38,39). In order to examine this 
possibility (Fig. 3A1), we have tested accessibility 
of the carboxy-terminal domain of Nup214 to the 
nuclear compartment in vivo. For this, we used a 
rapamycin-dependent heterodimerizer system 
(54). The small (95 amino acids) FRB protein, 
one of the two heterodimerizing components, was 
fused to the C-terminus of the RNAi-insensitive 
Nup214. The other heterodimerizing component, 
FKBP, was fused to either GST-NLS-GFP or the 
NES-deficient Rev(1.4)-GFP, two constitutively 
nuclear proteins that cannot freely diffuse across 
the NPC. As depicted in Figure 3A2-3, 
rapamycin-dependent dimerization would occur 
only if the C-terminal FRB containing domain of 
Nup214 could reach the nuclear compartment. 
Expression of Nup214-FRB rescued the effects of 
shRNA-induced Nup214/Nup88 depletion in 
Nup214 expression (Fig 3 B3,4 and C3,4) and 
NMD3 nuclear export (Fig 3 E). This indicates 
that the Nup214-FRB RNAi-insensitive derivative 
of Nup214 is correctly expressed, targeted to the 
NE and functional. Previous studies have shown 
that a fusion protein consisting of a FRB and Rev 
NES is small enough (~11.5 kD) and capable to 
diffuse freely through the NPC, indicating that the 
FRB component would not prevent the capacity 
of Nup214 C-terminus to cross the NPC (55). 
When Nup214-FRB and GST-NLS-GFP-FKBP 
were highly overexpressed (Fig 3D1:6), the two 
proteins colocalized in cytoplasmic dots in a 
rapamycin-dependent manner (Fig 3D2-3,5-6,8-
9), providing a control for rapamycin-induced 
heterodimerization. Furthermore, small amounts 
of cytoplasmic GST-NLS-GFP-FKBP were 
sufficient to induce a visible colocalization with 
Nup214 (Fig. 3D1,4,7). However, no rapamycin-
induced heterodimerization was detected when 
the nuclear reporter proteins were confined to the 
nucleus, using either GST-NLS-GFP-FKBP or 
Rev(1.4)-GFP-FKBP protein (Fig 3B2,4,6 and Fig 




Figure 4. Nup214 FG repeats are dispensable for 60S preribosomal nuclear export. (A) Rescue of GFP-NMD3 
nuclear export and Nup214 expression in Nup214/Nup88 depleted HeLa cells by exogenous Nup214. HeLa cells 
were transfected with Nup214-shRNA expression plasmids (right) or control plasmids (left) and co-transfected 
with RNAi sensitive or insensitive versions of a Nup214 expression plasmid as indicated below the graph. White 
bars represent percentages of cells showing cytoplasmic GFP-NMD3 staining greater or equal to nuclear staining. 
Black bars represent percentages of cells showing Nup214 staining at the nuclear envelope. Error bars represent 
standard errors. (B) Rescue of GFP-NMD3 nuclear export in Nup214/Nup88 depleted HeLa cells by Nup214 
deletion mutants. Nup214 deletion constructs are represented as horizontal bars. Dark boxes indicate central 
coiled coil domains; vertical bars, FG repeats; arrow, RNAi target. A black oval denotes a mutated RNAi target. 
Amino acid positions of Nup214 are shown at the bottom 1-2090 (asterisk). Bars graph at the right show the 
percentage of rescue obtained for each construct relative to the parental deletion construct (dashed line). Error bars 
represent standard error 
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domain of Nup214 is not able to access the 
nuclear compartment from its cytoplasmic site. 
 
Nup214 FG repeats are dispensable for 60S 
preribosomal nuclear export−In order to 
determine which region of Nup214 was required 
for preribosomal nuclear export, we designed 
several deletion constructs of Nup214 and 
expressed them in Nup214/Nup88 depleted cells. 
In order to ensure expression of the re-introduced 
Nup214 proteins, we designed four silent point 
mutations in the nucleotide sequence that is 
targeted by the Nup214 shRNA. To determine the 
extent of rescue that can be obtained in this setup, 
we transfected HeLa cells expressing GFP-NMD3 
under normal or Nup214/Nup88-depleted 
conditions with plasmids expressing either RNAi 
sensitive or insensitive Nup214 (Fig. 4A). In 
control cells, efficient nuclear export of NMD3 
was found in 84% cells and 86% of the cells 
showed a clear NE staining of Nup214. These 
scores were not significantly altered when wild 
type or RNAi-insensitive Nup214 were 
exogenously expressed. Upon depletion of 
Nup214/Nup88, only 23% of cells showed 
efficient nuclear export of GFP-NMD3. 
Concomitantly, the presence of Nup214 at the NE 
was reduced to 28% of cells. Neither GFP-NMD3 
export nor the expression of Nup214 were 
significantly enhanced when an RNAi-sensitive 
Nup214 mRNA was overexpressed, indicating 
that the exogenous Nup214 transcript was 
recognised and degraded by the RNAi machinery. 
In contrast, when the RNAi-insensitive version 
was re-introduced, 46% of cells were able to 
export GFP-NMD3. This coincided with a 
significant increase of Nup214 expression (Fig. 
4A). These data indicated specific rescue of 
shRNA-mediated depletion of Nup214/Nup88 by 
exogenous Nup214 DNA constructs and defined 
the dynamic range of the assay to be roughly from 
25 to 50% of wild-type. 
We next tested GFP-NMD3 nuclear export of 
Nup214/Nup88 depleted cells that lacked FG-
repeats to a varying extent (Fig. 4B). These 
derivatives were created by ExoIII deletion from a 
parental construct which had a small deletion 
from amino acid position 2055 to 2076 of the 
Nup214 sequence. This parental construct was 
able to rescue NMD3 export to levels comparable 
to the full length rescue plasmid. Interestingly, 
most FG-repeat deletions rescued to similar levels 
as the parental construct, and two constructs 
encoding Nup214 versions lacking the entire FG 
repeat domain (Nup214∆1637-2075 and Nup2141-1143) 
containing the CRM1 binding site were not 
significantly different in their capacity to rescue 
than the parental construct. Expression of 
Nup214∆1637-2075, Nup2141-1143 or HA-Nup153 did 
not rescue expression of endogenous Nup214 (Fig 
5A, B and not shown). We conclude that Nup214, 
but not its FG-repeat region, is essential for 60S 
preribosome export. 
 
Nup214 central coiled coil domains are 
sufficient for 60S preribosomal nuclear 
export−We have shown that Nup214 domain can 
not access the nuclear compartment. In addition, 
we have excluded the possibility that Nup214 
function in 60S preribosomal export is mediated 
by any carboxy-terminal mediated interaction. 
These facts suggest that Nup214 does not interact 
directly with the 60S export complex. In order to 
further test this possibility, we have expressed 
three versions of the central Nup214 coiled coil 
domains. These domains are required to mediate 
interaction with Nup88 and with the NPC (56,57). 
Incorporation of the HA1-tagged coiled coil 
domains into the NPC was analyzed by 
immunofluorescence and confocal microscopy 
imaging in Nup214-depleted HeLa cells. As 
shown before (56), while the first and second 
Nup214 coiled coils showed no or low NE 
staining (Fig 5A, 14 and 15 respectively), the 
protein containing both domains was targeted to 
the NE very efficiently (Fig 5A, 16). 
Analogously, Nup88 NE staining was found as 
high as wild type levels only when the construct 
containing both coiled coils of Nup214 was 
expressed (Fig 5C, D). Next, we analyzed NMD3 
export by confocal microscopy imaging. While 
cells expressing the first or second coiled coil 
domains (Fig 5B) of Nup214 elicited no or little 
rescue on NMD3 export assays (Fig 5A6,7), cells 
expressing the complete central domain (585-
1058) rescued NMD3 export capacity to the same 
extent as the Nup214 RNAi insensitive construct 
(Fig 4B and 5A8). Western blot analysis of HeLa 
cell extracts expressing shRNAi targeting Nup214 
and co-transfected with HA-Nup153, 
Nup214∆1637-2075, Nup214585-832, Nup214804-1058 or 




Figure. 5. Nup214 central coiled coil domains are sufficient for 60S preribosomal nuclear export. (A). Subcellular 
distribution of GFP-NMD3 expressing HeLa cells 72 hours after co-transfection with pSUPER control (A1,9 
5,13) or pS-Nup214; and with empty pcDNA (A2,10) or Nup214 rescue plasmids expressing Nup214∆1637-2075 
(A3,11), Nup2141-1143 (A4,12), Nup214585-832 (A6,14), Nup214804-1058 (A7,15) and Nup214585-1058 (A8,16). Cells 
were fluorescently labelled with anti-hNup214 (A9:12) and anti-HA 12CA5 (A13:16) primary antibodies and 
Texas Red labeled secondary antibodies. (B). Western Blot of HeLa cells transfected with pSUPER empty (lane 
7) or pS-Nup214 (lanes1:6). HA-Nup153 (lane 2), Nup214∆1637-2075 (lane 3), Nup214585-832 (lane 4), Nup214804-1058 
(lane 5) and Nup214585-1058 (lane 6) were co-transfected. Blots were probed for Nup214, Nup153 using MAb 414, 
for Nup214∆1637-2075 using anti-hNup214 and for HA1 using 12CA5. (C) Nup214 coiled-coil region is sufficient to 
target Nup88 to the NPC. Graphic representation showing fluorescence levels of endogenous Nup88 as a 
percentage of the empty pSUPER negative control after knockdown of Nup214 and co-expression of the indicated 
plasmids. Representative images are shown in (D); note that absence of Nup214 reduces endogenous levels of 
Nup88 (see also Fig. 1E). 
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showed that endogenous Nup214 levels continued 
to be significantly reduced, indicating that their 
expression did not interfere with Nup214 RNAi.  
HA-Nup153 expression also did not rescue 
NMD3 export (data not shown). These results 
indicate that Nup214 function in 60S export is 
mediated by the central domain of Nup214, which 




In this study we have assessed the role of 
the Nup214/Nup88 complex in CRM1-mediated 
nuclear export. Human CRM1 was first identified 
as a Nup214 co-precipitating protein that 
interacted specifically with the C-terminal FG-
repeat of this nucleoporin (21). In vitro, this 
interaction is enhanced by RanGTP and cargo, 
suggesting a role in translocation through the 
NPC or disassembly of export complexes (36). It 
was therefore surprising that depletion of the 
Nup214/Nup88 subcomplex had little or no effect 
on CRM1-dependent nuclear export of simple 
export cargos. In yeast, a relatively strong in vitro 
interaction between Nup159 and Xpo1 exists as 
well (26), suggesting that this interaction has an 
important evolutionary conserved function. 
However, removal of the high affinity domain in 
Nup159 does not significantly affect nuclear 
export of an NES-GFP-NLS reporter protein (26) 
or cell viability. Furthermore, studies in yeast 
indicate that a significant fraction of FG-repeats 
can be removed from the NPC before cell 
viability is compromised (25). Therefore, the in 
vivo significance of the high affinity 
CRM1/Nup214 interaction remains unknown.  
In addition to contributing to the 
hydrophobic inner core of the NPC (8), the FG-
repeat region of Nup214 has recently been 
proposed to move cargo through the NPC from 
the nuclear to the cytoplasmic face of the NE 
(38,39). In fact, the FG-repeat region of Nup214 
is able to cross the NPC by itself (58), is predicted 
to be unstructured (59), and long enough to cross 
the NPC from a cytoplasmic anchoring point. In 
addition, overexpression of Nup214 results in a 
presence of this nucleoporin at both sides of the 
NPC (60). But, irrespective of such a system 
operating, our Nup214 depletion data indicate that 
it is not essential for CRM1-mediated nuclear 
export in cultured cells. To examine whether the 
C-terminal tail of Nup214 reaches the nuclear 
face of the NPC in vivo, we provided GFP 
reporter proteins and the C-terminal tail of 
Nup214 with rapamycin-dependent 
heterodimerizing tags. Using this system, we only 
detect NPC localization of the reporter proteins 
when they are in the cytoplasm, indicating that the 
FG repeat region of Nup214 can access the 
cytoplasm but not the nucleoplasm. 
We found that the presence of the 
Nup214/Nup88 subcomplex was required for 
CRM1-mediated nuclear export of 60S pre-
ribosomal subunits. This indicates that different 
cargos served by the same transport receptor have 
different nucleoporin requirements, which 
complements earlier observations that different 
nucleoporins serve distinct nucleocytoplasmic 
transport pathways (61-64). Because depletion of 
Nup214 has no general effect on nuclear protein 
import (34), or export (this study), the observed 
preribosomal nuclear export defect is likely not a 
consequence of pleiotropic effects on other 
nuclear transport pathways. 
The mechanism by which large 
ribonuclear protein complexes translocate though 
the NPC remains largely unknown. The size of a 
60S preribosomal particle (25 nm) is 
approximately 100-fold a GFP molecule and close 
to the upper NPC size limit for a non-deformable 
cargo (65) suggesting that a significant 
conformational change of the NPC should occur 
during its translocation. Recent analysis using 
cryoelectron tomography of functional 
Dyctiostelium NPCs has revealed distinct 
structural states correlating with a variable central 
volume that likely represented large cargo in 
transit (32). 
In yeast, nuclear export of 40S and 60S 
preribosomes was reported to require the 
Nup159p/Nup82p/Nsp1p subcomplex (37), which 
is the proposed yeast homologue of the vertebrate 
Nup214/Nup88/Nup62 subcomplex (57). Both 
Nup214/Nup88/Nup62 and Nup159/Nup82/Nsp1 
subcomplexes are associated through interactions 
of coiled-coil domains (56,57) and these domains 
in Nup159p and Nsp1p are necessary and 
sufficient for cell viability (66,67). We find that in 
vertebrate cells, the requirement of the 
Nup214/Nup88 subcomplex for 60S preribosomal 
export is dependent on the central coiled coils 
domain that contains the Nup88 and possibly 
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Nup62 interaction domains but not on its N-
terminus nor its large FG repeats region. Because 
of the structural characteristics of the Nup214 
central domain and its role in correctly 
positioning the cytoplasmic Nup214/Nup88 
subcomplex, it is likely part of the cytoplasmic 
structures of the NPC. Furthermore, this region 
lacks FG repeats, thought to be essential for 
CRM1 interaction. Therefore, we consider it 
unlikely that a direct interaction between Nup214 
and the 60S preribosomal export complex is 
required for 60S export. We rather propose that 
the Nup214/Nup88 core domain plays a structural 
role in large scale conformational changes 
required for 60S preribosome export, perhaps 
functioning in a hinge-like manner. This is 
consistent with deletion analysis in yeast, 
indicating that only the coiled-coil domain of 
Nup159, the closest yeast homologue of Nup214, 
is required for 40S preribosomal nuclear export 
(37). Further evidence that the Nup214/Nup88 
subcomplex is required for nuclear export of large 
cargoes is the strong mRNA export defect of 
depletion of Nup214 and Nup88 (35,68), or their 
yeast equivalents Nup159 and Nup82 (61,62,69). 
In conclusion, we have shown that the 
Nup214/Nup88 subcomplex is required for 
CRM1-mediated export of a specific cargo, the 
60S preribosome, in a process independent of 
strong CRM1-FG interactions.  
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“La Biblia cuenta una historia, 
que un dios terrible dictó. 
El drama de dos hermanos, 
el justo y el traidor. 
Abel mezquino y cobarde, 
el siervo de su señor. 
Caín que no entró en el juego, 
y que se rebeló. 
[...]
Quizá los hombres seamos, 
a un tiempo Abel y Caín. 
Quizá algún día destruya, 
lo oscuro que hay en mí. 
El destino no está marcado al nacer. 
Yo he elegido ser lo que siempre seré.  
Hijo de Caín”  
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Overexpression of an aberrant fusion between the nucleoporin Nup214 and the protein tyrosine 
kinase Abl1 is frequent in T-cell Acute Lymphoblastic Leukemias (T-ALL). We have studied 
the localization, nuclear pore complex (NPC) interaction and function of the protein encoded 
by the translocation product NUP214-ABL in order to increase our understanding in the role of 
this nucleoporin fusion in leukemogenesis. We have found that NUP214-ABL1 interaction 
with the NPC is equivalent to that of Nup214. NUP214-ABL1 deletions that contained the 
central coiled coils were sufficient for NPC incorporation but not for tyrosine kinase activity 
auto-activation and transformation, Abl1 downstream targets were not phosphorylated and an 
undescribed phosphorylation of Nup358 was found. We propose that the NPC provides a 
platform that permits, under optimal conditions, proximity autophosphorylation and activation 




Chromosomal translocations are implicated in many human malignancies. One well 
characterized example is the Philadelphia translocation, a BCR-ABL fusion protein with 
constitutive protein kinase activity that alters the signaling pathways that control the 
proliferation, survival, and self-renewal of hematopoietic stem cells. It is typically found in 
Chronic Myeloid Leukemia (CML) and precursor B-cell Acute Lymphoblastic Leukemia (B-
ALL) (De Klein et al., 1986; De Klein et al., 1982). This translocation is rare in T-cell Acute 
Lymphoblastic Leukemias (T-ALL) (Pui et al., 2004). Very recently, a novel transcript product 
of the fusion of the oncogenes NUP214 and ABL1 was described in T-ALL patients and cell 
lines (Graux et al., 2004). The recurrent rearrangement leads to the expression of a 
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constitutively phosphorylated tyrosine kinase. As is the case for ABL1, NUP214 translocations 
have been described previously in leukemias (von Lindern et al., 1992; von Lindern et al., 
1990; von Lindern et al., 1992). These data suggest that this nucleoporin may play an important 
role in the development of this disease. In contrast to other translocation products that contain 
Nups, NUP214-ABL1 lacks most of the characteristic FG repeats domain, thought to be 
implicated in oncogenic transformation (Ahuja et al., 1999; Arai et al., 1997; Borrow et al., 
1996; Hussey et al., 1999; Kasper et al., 1999; Nakamura et al., 1996).  
Our study focused on the characterization of NUP214-ABL1. We have studied its localization 
and function in T-ALL cells lines and in transfected cells. We show that this fusion localizes to 
the NPC and interacts with Nup358, Nup88 and Nup62. The NPC localization and nucleoporin 
interaction is dependent on the Nup214 coiled coils domain, which is however not sufficient 
for activation of Abl1 downstream targets. Also other Nup214 domains were not sufficient in 
these respects, suggesting that multiple Nup214 domains contribute to Nup214-Abl1 oncogenic 
activity. In addition, a Nup214-Abl1-dependent tyrosine phosphorylation site was found on 
Nup358. We propose a proximity mechanism, based on the structure and composition of NPC, 
for NUP214-ABL1 auto activation and oncogenicity. 
 
Materials and Methods 
 
Antibodies− Anti-hNup358V and anti-hNup358F were generously provided by V. Cordes (Karolinska 
Institute, Stockholm, Sweden) and F. Melchior (Max Planck Institute for Biochemistry, Munich, 
Germany), respectively. Antibodies to Nup214 (Bernad et al., 2004), anti-CAN9977 (Fornerod et al., 
1995), anti-hNup88 (BD Transduction Laboratories), Anti-Nup62 (BD Transduction Laboratories), 
Anti-Nup358 (Santa Cruz, N-20), monoclonal antibody (MAb) 414 (Eurogentec/Babco), Anti-ABL1 K-
12 (Santa Cruz), Anti-ABL1 8E9 (BD Transduction Laboratories), Anti-phospho-ABL1 Tyr245 
(Sigma), Anti-phospho Tyr(4G10) (Upstate), Anti-ERK2 (Santa Cruz), Anti-phospho-ERK1/2 (Cell 
Signaling) and anti-HA (12CA5) were previously described.  
Cell culture and retroviral transduction−HEK 293T and Ba/F3 cells were cultured, transfected and 
transduced as described previously (Cools et al., 2003). Transduced Ba/F3 cells were selected with 
puromycin (2.5µg/ml) or neomycin (600µg/ml medium) and grown in the presence of IL-3 (1ng/ml) 
when required. For growth curves, 105 Ba/F3 cells were seeded in 1 ml medium and viable cells were 
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Figure 1: Immunofluorescence of ALL cell lines JURKAT, PEER, BE-13 and ALL-SIL. Note that all cell lines, 
except JURKAT, are NUP214-ABL positive. Cells were fluorescently double-labeled with anti-Abl K12 in 
combination with mAb414, anti-hNup88, or anti-Nup62; or anti-Abl8E9 in combination with and anti- hNup214 
or anti-CAN9977. (Full-color merges shown in cover flap). 
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RPMI-1640 + 20% FCS. 
Immunoprecipitations-107 cells were lysed for 30 minutes in ice, spun and incubated for 1-2 hours with 
pre-clear Protein-G-Sepharose in lysis buffer. After centrifugation, pre-cleared lysate was incubated 
with antibody-coupled beads for 4 hours and washed with lysis buffer. For loading on SDS gel, beads 
were resuspended in Nupage SDS loading buffer supplemented with reducing agent. 
Immunofluorescence stainings and image analysis−Indirect immunofluorescence was performed as 
previously described (Bernad et al., 2004). Cells were spun at 1200 rpm for 1 min prior to fixation. 
Images were recorded with Leica TCS NT2 and SP2 confocal microscopes. 
 
Results and Discussion 
 
NUP214-ABL1 is targeted to the NPC. Nup214-ABL1 fusion proteins contain the central 
coiled-coil region of Nup214 that mediate targeting to the NPC (Chapter 5 and (Belgareh et al., 
1998; Fornerod et al., 1996). To determine whether Nup214-Abl1 is localized to the NPC, we 
used immunofluorescence and confocal imaging on several malignant T-cell lines: JURKAT, 
ALL-SIL, BE-13 and PEER. With the exception of the JURKAT cells, all of them expressed 
Nup214-ABL1 fusion (Graux et al., 2004). As shown in Figure 1, only NUP214-ABL positive 
cell lines showed nuclear envelope localisation of Abl1 epitopes, presumably representing the 
fusion product. To confirm that NPC localization of Nup214-Abl1 is mediated by the central 
coiled-coil region of Nup214, we performed immunolocalization assays on Ba/F3 cells 
expressing either full length NUP214-ABL1 or deletion constructs (Fig. 2, A). The NUP214-
ABL1 deletion that contained the coiled coils incorporated to the NPC (Figure 2, B), whereas 
constructs that lacked the coiled-coils were located in the cytoplasm. This result indicates that 
Nup214 central coiled coils are required for NUP214-ABL1 incorporation to the NPC. 
 
NUP214-ABL1 interacts with Nup62 and Nup88. NUP214-ABL1 NPC localisation seen by 
immunofluorescence prompted us to study the capacity of this fusion to interact with Nup214 
NPC interaction partners Nup62 and Nup88 (Belgareh et al., 1998; Fornerod et al., 1996). We 
performed immunoprecipitation assays on ALL-SIL (containing NUP214-ABL1, (Graux et al., 
2004) and K-562 (containing BCR-ABL1, (Wu et al., 1995) cell lines and we were able to co-












































































































Figure 2(A) Schematic representation of NUP214-ABL1 fusion products and deletion derivatives developed. 
Nup214 aminoacid positions are marked. FG: Phenylalanine glycine. (B) Immunofluorescence of Ba/F3 cell lines 
expressing Nup214-ABL1, Nup214-N-ABL1, Nup214-C-ABL1 and Nup214-coils-ABL1 (left to right). Cells 
were fluorescently double-labeled with anti-Abl K12 (B1:4); or anti-Abl8E9 (B5:8).  
shown). Also, we could detect ABL1 using Nup62 antibodies as bait (Figure 3, B). To test the 
capacity of NUP214-ABL1 deletion constructs to interact with Nup62, we transduced Ba/F3 
cells and performed IPs using ABL1 antibodies. As expected, only the deletion that contained 
the coiled coils domain showed interaction with Nup62 (Figure 3, C). These results further 
confirm that NUP214-ABL1 interaction with the NPC is analogous to that of Nup214. 
 
Deletions of NUP214-ABL1 suppress Ba/F3 transformation capacity. Oligomerization of 
fusion kinases is a recurrent mechanism of transformation (Golub et al., 1996). Nup214 
contains two central coiled coils (Belgareh et al., 1998; Fornerod et al., 1996). In order to test 
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Figure 3: (A and B) Immunoprecipitations of leukaemya cell lines K562 and ALL-SIL. Note that K562 contains a 
BCR-ABL1 traslocation and ALL-SIL a NUP214-ABL translocation. Antibodies to ABL1 (A), or Nup62 (B) 
couple to protein G sepharose were incubated with cell extract and coimmunoprecipitating proteins analysed by 
labelling a Western blot with anti- Nup62 or anti-Nup88 (A); or anti-P-Tyr 4G10 or anti-ABL1 (C). ABL1 
immunoprecipitation on extracts from Ba/F3 cells expressing BCR-ABL1, Nup214-ABL1, Nup214-N-ABL1, 




whether the Nup214 central coiled coils domain is sufficient to induce transformation, we 
performed factor-independent growth assays on Ba/F3 cells expressing either BCR-ABL1, full 
length NUP214-ABL1 or the deletion derivatives shown in Fig. 2A. The growth curve shows 
that full length NUP214-ABL1 transformation ability is low in comparison to BCR-ABL1 (Fig 
4). Neither the NUP214-coils-ABL1 (Fig 4) nor any of the other deletion proteins (data not 
shown) were capable to induce IL3-independent growth. This result suggests that neither 
simple dimerization of Nup214 via the coiled-coil region or insertion into the NPC are unlikely 
to activate Abl1 and that multiple domains of Nup214 contribute to its transforming capacity. 
 
Deletions of NUP214-ABL1 alter phosphorylation targets. Constitutively activated kinase 
activity of ABL1 plays a central role in leukemogenesis (Pui et al., 2004). We have studied 
ABL1 kinase activity on cells expressing NUP214-ABL1 constructs. We only detected 
phosphorylation on ABL1 tyrosine 245 when full length NUP214-ABL1 was expressed (Fig 
5A, upper panel). This phosphorylation was inhibited by Imatinib indicating that is dependent 
on Abl1 kinase activity. Interestingly, antibodies against tyrosine 245 phosphorylated ABL 
cross-react to a protein running at ~350 kDa that co-migrates with full length Nup214-ABL1 
when ABL1 proteins constructs containing Nup214 coiled coils were expressed (Fig. 5A upper 
panel, asterisks). This band was found to correspond to Nup358 (not shown) which may react 
to the anti-P-Abl1 antibody due to a region of similarity around tyrosine 785 of Nup358 (Fig. 
5B). This suggests that ABL1 preserves kinase activity when incorporated into the NPC. 
Figure 4. Il3-independent 
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However, only expression of full length NUP214-ABL1 could induce phosphorylation of the 
ABL downstream target ERK2 (Towatari et al., 1997).This finding indicates that hyperactivity 
of the Abl1 kinase is defined by multiple Nup214 domains including those required for NPC 
localization. One possibility is that only the full length Nup214-ABL1 as incorporated in the 
NPC brings the ABL1 kinase domains in sufficient proximity for autophosphorylation and 
subsequent hyperactivity to occur. We have previously shown that the Nup214 coiled coils 
domain by itself can incorporate into the NPC efficiently (Chapter 5, Fig 5). We predict that 
overexpression of these coils will be able to compete NUP214-ABL1 out of the NPC. 
Analysing transformation potential and NUP214-ABL1 under these conditions may reveal if 
NPC targeting is required for NUP214-ABL1 oncogenic transformation. 
Figure 5 A. Western blot analysis of Ba/F3 cell extracts 
expressing Nup214-ABL1, Nup214-coils-ABL1, 
Nup214-N-ABL1, Nup214-C-ABL1, BCR-ABL1, 
Nup214-C+coils-ABL1, and Nup214-N+coils-ABL1 or 
empty MSCV (left to right) in the presence or absence of 
Imatinib 10µM. Anti-P-Tyr 245, anti-RanBP2, anti-
ABL1 Anti-phospho-ERK1/2, Anti-ERK2 antibodies 
were used. Asterisks represent cross-reacting band. B. 
Alignment of the Tyr245 phosphorylation site of ABL1 
and a region of similarity in Nup358.  
 
Nup358 localisation is not perturbed on NUP214-ABL1 positive cell lines. Nup358 is 




Nup358 localisation is not perturbed on NUP214-ABL1 positive cell lines. Nup358 is 
hyperphosphorylated in mitosis (Favreau et al., 1996). This process is thought to be related 
with NPC disassembly. We reasoned that abnormal phosphorylation on Nup358 tyrosine 785 
may provoke aberrant Nup358 disassembly. We studied the localisation of Nup358 on the 
 
 
Figure 6 Immunofluorescence 
of ALL cell lines JURKAT and 
PEER. Note that JURKAT cell 
line is NUP214-ABL negative. 
Cells were fluorescently 
double-labeled with anti-Abl 




NUP214-ABL1 positive PEER cell lines. Immunofluorescence images show no major change 
in Nup358 localisation on these cell lines suggesting that Nup358 tyrosine 785 phosphorylation 
does not provoke its disassembly from the NPC (Figure 6). We suggest that Nup358 
phosphorylation is a consequence of the proximity to NUP214-ABL1.  
In conclusion, we have shown that NUP214-ABL1 is targeted to the NPC in a manner 
analogous to Nup214. Furthermore, our data indicate that activation of Nup214-ABL1 is not 
mediated by simple dimerization, but that multiple domains of Nup214 are required. Resistance 
to treatment with Imatinib mesylate in chronic myeloid leukemia (CML) and some NUP214-
ABL positive cell lines was reported (Graux et al., 2004; Shah, 2005). Alternative therapies for 
treatment are then of great interest. Taking advantage of our current knowledge about the 
dependency on protein stability of the two components of the Nup88-Nup214 subcomplex 
(Chapter 3) and the toxic effects of the FG-domain of Nup214 (Boer et al., 1998), we will 
perform Nup88 knockdowns and Nup214∆FG or Nup214 coiled coils overexpression on 
NUP214-ABL positive cells lines to study possible changes on NUP214-ABL stability and 
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Establishment of communication between the nuclear and cytoplasmic compartments is crucial 
for eukaryotic life. The nuclear pore complex (NPC) is a multiproteinic structure adapted to 
elicit nucleocytoplasmic shuttling of a broad variety of molecules ranging from ions to 
complex ribonuclear proteins. It is of great interest for the understanding of cell biology to 
elucidate how this is accomplished. This thesis contains intellectual and experimental work that 
improves the current knowledge concerning nuclear transport. 
 
1. How are the cytoplasmic Nups organized? 
 
The NPC is composed of several copies of each of the ~20 different components, denominated 
nucleoporins or Nups (Cronshaw et al., 2002; Rout et al., 2000). We studied the localization of 
these individual components to elucidate their neighbor counterparts and function. We have 
used electron microscopy techniques on Xenopus egg extracts to localize Nup88 (Chapter 3, 
Fig. 1) and map it in relation to Nup214 and Nup358, the other cytoplasmic oriented Nups 
(Walther et al., 2002). We show that Nup88 is in close proximity to both Nups. It has been 
shown before that Nup214 and Nup88 form a stable association (Bastos et al., 1997; Fornerod 
et al., 1997; Matsuoka et al., 1999). This fact prompted us to further investigate the physical 
interactions between Nup88 and Nup358. We found that, as with Nup214, Nup88 and Nup358 
interact (Chapter 3, Fig. 2). Interestingly, the interaction between Nup88 and Nup214 was 
detected as well and we could not exclude other Nups mediating interaction with Nup358. This 
suggests that Nup358 interacts with Nup88 when associated with Nup214 in a subcomplex. 
Further evidence of this fact was found when we studied protein stability and localization of 
Nup88, Nup214 and Nup358 in HeLa cells under normal conditions or after RNA interference-
mediated depletion of each individual component. We found that Nup358 could no longer 
incorporate to the nuclear envelope (NE) when the Nup214/Nup88 subcomplex was absent 
(Chapter 3, Fig. 3). This finding indicates that the Nup214/Nup88 subcomplex is the anchoring 
site of the cytoplasmic filaments to the NPC and establishes the hierarchy of interactions for 
the cytoplasmic Nups.  
NPCs undergo organised rounds of disassembly and re-assembly every cell cycle and Nups 
show a dynamic behaviour during interphase (Doye and Hurt, 1997; Rabut et al., 2004; Ryan 
and Wente, 2000). These facts indicate that Nups need to be tightly regulated. Nups associate 
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in subcomplexes prior to incorporation to the NPCs. We studied the fate of the components of 
the Nup214/Nup88 subcomplex when their expression was inhibited through RNAi. We 
showed a co-dependence of these Nups in both protein stability and NPC incorporation 
(Chapter 3, Fig. 3 and 4) which is in turn required for Nup358 NPC incorporation. Intriguingly, 
microarray based expression profiles showed that Nup88 and Nup214 had a tendency for co-
regulation (Perou et al., 1999; Ross et al., 2000), indicating that transcription of these two Nups 
is tightly coordinated. The mechanism of these networks is not clear but it is likely to serve as a 
system to maintain the correct stoichiometry for these NPC components. Nup88 function is 
largely unknown. Proteomic analysis of the NPC indicate that it is 4-fold more abundant than 
Nup214 at the NPC (Cronshaw et al., 2002). The reason for this higher abundance of Nup88 
may be related to its capacity to interact with other NPC components (Griffis et al., 2002) and 
surplus Nup88 explains why in vitro reconstituted nuclei from Nup214 depleted Xenopus still 
retain Nup358 (Walther et al., 2002).  
Electron microscopy techniques have provided extensive information of the NPC structure 
(Akey, 1989; Beck et al., 2004; Goldberg and Allen, 1993; Stoffler et al., 2003). In contrast, 
very little is known about how this macromolecular complex is constructed at atomic 
resolution. The main reason for this is the unstructured nature of many Nups provided by the 
presence of repeated phenylalanine and glycine motifs (FG-repeats) (Denning et al., 2003), 
which impedes the crystallization procedure. Solving Nup214/Nup88 subcomplex structure at 
the molecular level may provide very important information towards understanding how NPC 
subcomplexes assemble. We have shown that Nup214 and Nup88 stability is maintained upon 
co-expression (Chapter 3, Fig. 4) and we have mapped the Nup214 domain that mediates 
Nup88 stabilization to a central region containing two coiled coils (Chapter 5, Fig. 5 and 
(Fornerod et al., 1996). We propose to co-express this domain with Nup88 in an attempt to 
obtain a stable and structured complex for crystallization.  
 
2. What is the role of Nup358 in nuclear transport? 
 
Transport receptors and the Ran system co-operate with the NPC to achieve nucleocytoplasmic 
transport (Allen et al., 2000; Bayliss et al., 2000; Görlich and Kutay, 1999; Hetzer et al., 2005; 




FG-domain containing Nups and promote translocation of their cargoes (Allen et al., 2001; 
Bayliss et al., 2002; Görlich et al., 1997). Interestingly, differential binding affinities exist 
between transport receptors and specific FG-Nups (Iovine et al., 1995; Strawn et al., 2001) 
suggesting that these interactions may be relevant for nuclear transport. It has even been 
proposed that an affinity gradient for transport receptors mediates nuclear translocation (Ben-
Efraim and Gerace, 2001). However, recent evidence shows that most FG-repeats, especially 
those of asymmetric Nups, are dispensable for NPC viability, exclusion diameter and transport 
in yeast (Strawn et al., 2004; Zeitler and Weis, 2004). In a typical round of CRM1-mediated 
export (Chapter 2, Fig. 3), this transport receptor binds a NES-containing cargo in the presence 
of RanGTP and releases it upon RanGTP hydrolysis in the cytoplasm. Nup358 contains four 
RanBP1-like RanGTP binding domains that act as RanGTPase coactivators (Beddow et al., 
1995; Bischoff et al., 1995; Richards et al., 1995; Villa Braslavsky et al., 2000), and two 
RanGDP binding Zinc-finger domains (Yaseen and Blobel, 1999). Nup214 contains, in 
addition to the two central coiled coils domains that associate with Nup88 and target them to 
the NE, a carboxy-terminal FG-repeat domain that strongly binds the export receptor CRM1 
(Fornerod et al., 1996; Fornerod et al., 1997). None of the cytoplasmic Nup214 nor Nup358 
were required to mediate import of proteins on in vitro assembled NPCs (Walther et al., 2002) 
indicating that they may play a role in export. For that reason our work focused on the function 
of the cytoplasmic Nups in export pathways. First, we have found that Nup358 depletion 
provoked a defect on export when we used a sensitive Rev-GFP export assay (Chapter 3, Fig. 
6). Furthermore, we show that this Nup can hold empty CRM1 at the cytoplasmic side of the 
NPC (Chapter 3, Fig. 5). These results suggest that Nup358 may have a role in CRM1-
mediated export as a supporting element providing the platform where the export complexes 
are disassembled. Studies performed on supraphysiological nuclear export signals (NES) 
further strengthen this hypothesis (Chapter 4). These superNESs bound CRM1 strongly 
independently of RanGTP. Export complexes containing a superNES accumulated at Nup358 
after NPC translocation (Chapter 4, Fig 4 and 5), suggesting that cargo release is less efficient 
and that export complex disassembly occurs at Nup358. The fact that freely diffusing 
cytoplasmic RanBP1 is capable to perform the same reaction (Beddow et al., 1995; Bischoff et 
al., 1995; Richards et al., 1995; Villa Braslavsky et al., 2000) explains why, in contrast to the 
results found in Drosophila that lacks RanBP1 homologue (Samaklovis, personal 
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communication), many depleted cells are still capable of exporting substrates even in a 
sensitive export assay. In addition, it further suggests that Nup358 is the immediate location 
where export complexes can disassemble upon translocation and release cargo while retaining 
emptied CRM1 for a rapid recycling to the nucleus (Chapter 4, Fig 7). A similar model of 
empty receptor retention has been proposed for the NFX1-p15 heterodimer mRNA export 
receptor, which was not present at the NPC upon depletion of Nup358 in Drosophila (Forler et 
al., 2004). All these facts indicate that Nup358 presence at the NPC increases the efficiency of 
export.  
 
3. Why are nuclear export signals born to be weak? 
 
We have selected NESs with strong, RanGTP independent, CRM1 affinities and shown that 
they are not optimal for export. In contrast to other export receptors CAS, exportin-t and 
exportin-4 (Kutay et al., 1997; Kutay et al., 1998; Lipowsky et al., 2000), the affinity of 
CRM1-RanGTP complex for endogenous NESs is weak (Askjaer et al., 1999; Paraskeva et al., 
1999). Irrespective of their weakness, NESs are diverse and they provide with different export 
efficiencies to the proteins that contain them (Henderson and Eleftheriou, 2000). Our results 
show that weak affinities are not trivial but crucial for efficient export (Chapter 4). 
Furthermore and since supraphysiological NESs arrest only after nuclear translocation, they 
suggest that, under physiological conditions, the affinities of NESs for CRM1 contribute to 
export efficiency by determining the rate of export complex assembly and disassembly, but not 
by altering the translocation process itself.  
But, are supraphysiological signals functioning in nature? We have shown that they may 
provoke toxic effects at high levels (Chapter 4, Fig 5), suggesting that they may play a role in 
the pathology of infection. It has been shown that Nup358 is required for kinetocore assembly, 
implicating CRM1 pathway in mitosis (Salina et al., 2003). SuperNES may have a function 
different to export after nuclear envelope breakdown by regulating CRM1 in mitosis. 
Recycling of the small nuclear ribonucleoprotein import receptor snurportin is mediated by 
high affinity interaction with CRM1 indicating that strong interactions can occur in cells with 
no deleterious effect (Paraskeva et al., 1999). This can be possible at low concentrations or in 




ribosomal export adaptor NMD3 (Thomas and Kutay, 2003; Trotta et al., 2003) contains a 
targeting signal that resembles the strong NES consensus (Kutay and Guttinger, 2005) and 
shows under certain conditions, (when tagged with protA), very strong CRM1 affinity (Chapter 
4, Fig 3 and 6). Although this effect can be considered as an artifact provoked by the alteration 
of the sequences around the NES, its presence in preribosomal export complexes is intriguing. 
A possible reason for the requirement of strong NESs would be that the residence time at the 
nuclear side of the NPC would have to be longer for certain type of particles. Strong NESs 
would be required for sufficiently long interaction between the NPC and the export complex. 
As simple supraphysiological NES cargoes accumulate at the NPC, the preribosomal particle 
(as well as snurportin) should have a specific release mechanism to prevent this. Further 
investigation should be performed to address this possibility.  
 
4. What is the role of the high affinity interaction between Nup214 and 
CRM1? 
 
When we depleted Nup214 by RNAi, we found only moderate defects in export of three 
different reporters: a PKI NES-bearing GFP molecule and two Rev-GFP reporters containing 
Rev-NES and the supraphysiological NESs S1 (Chapter 5, Figs 1 and 2), These defects are 
comparable to an absence of Nup358 at the NPC, known to be dependent on the 
Nup214/Nup88 subcomplex (Chapter 3, Fig 3), indicating that these Nups are not essential for 
CRM1-mediated export and suggesting that the in vitro high affinity of CRM1 for the Nup214 
FG-domain may not reflect any function of Nup214 in CRM1-mediated transport. This result is 
in agreement with the results found on yeast strains devoid of FG-Nups (Strawn et al., 2004; 
Zeitler and Weis, 2004). Furthermore, Zeitler and co-workers fused the Nup159 (Nup214 yeast 
homologue) high affinity Xpo1 (CRM1) binding domain to the nuclear Nup1 and showed that 
NES mediated export was not compromised. All these data clearly argue against a gradient 
affinity model for nuclear transport (Ben-Efraim and Gerace, 2001), that consider asymmetric 
FG-domains essential. We propose that the FG-domain of Nup214 may participate redundantly 
on the formation of the NPC kinetic/hydrophobic barrier. As is the case for Nup358, Nup214 
may play a role in mitosis regulating CRM1 activity and/or localization (Salina et al., 2003). 
As an alternative of the affinity gradient model, it has been proposed that the Nup153 and 
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Nup214 domains that contain high affinity binding sites for transport receptors are able to cross 
the NPC barrier and escort the transport complex through the pore (Fahrenkrog et al., 2002; 
Paulillo et al., 2005). Our in vivo studies on cytoplasmic-Nups depleted cells exclude this 
possibility for CRM1 export. Furthermore, we show that Nup214 can not access the nuclear 
compartment in vivo (Chapter 5, Fig. 3), indicating that this model is not applicable to Nup214. 
We consider that the reason for this discrepancy is that sub-optimal antibody specificity and 
sample processing for electron microscopy led Paulillo and co-workers to a incorrect 
interpretation of the data. Nevertheless, the fact that the high affinity interaction between 
Nup214 and CRM1 is conserved indicates that it has a function, possibly implicated in the 
retention and recycling of empty CRM1, as the domain swap experiment suggests (Zeitler and 
Weis, 2004).  
 
5. Is there a specific role for Nup214/Nup88 subcomplex in nuclear export? 
 
Our studies on NLS-GFP-NES and Rev-GFP assays showed that depletion of Nup214/Nup88 
subcomplex provoked a moderate export defect which can be attributable to the consequent 
lack of Nup358 at the NPC (Chapter 3, Fig. 3). However, we found a dramatic export defect of 
the ribosomal export adaptor NMD3. Since NMD3 mediates export of the 60S preribosomal 
subunit (Ho et al., 2000; Thomas and Kutay, 2003; Trotta et al., 2003; Warner, 2001), a 
consequent delay in preribosome export and maturation occurred when Nup214 was reduced 
(Chapter 5, Fig 2). This indicates that Nup214 is implicated in this specific transport process. 
Also, it shows that diverse cargos utilizing the same export receptor can trigger different 
transport mechanisms and raises the possibility that transport mechanisms are defined by the 
characteristics of the cargo or the cargo-transport receptor interaction. Intriguingly, a minimum 
Nup214 derivative containing the central coiled coil domains were able to restore NMD3 
export capacity (Chapter 5, Fig. 5). This domain is required for Nup88 interaction and NPC 
incorporation, probably through Nup62 binding (Chapter 5, Fig. 5 and (Belgareh et al., 1998; 
Fornerod et al., 1996). Considering the size of the central Nup214 coiled coil domain and that 
Nup214 localises to the cytoplasmic side of the NPC (Walther et al., 2002), we can exclude 
any direct interaction between the preribosomal export complex and Nup214 as a requirement 




domains: participation in the barrier through its FG-rich domain and 60S export through 
association with Nup88 and Nup62.  
More extensive research is required to further determine whether all large complexes require a 
specific transport mechanism for translocation irrespective of their transport receptor. 
Messenger RNPs are large complexes. They are exported by specific export receptors and 
require the action of specific RNA helicases and adaptor proteins (Huang et al., 2003; 
Izaurralde, 2004; Reed and Hurt, 2002). Furthermore, the mRNA export receptor affinities are 
regulated by phosphorylation suggesting the existence of an alternative release mechanism for 
mRNAs (Gilbert and Guthrie, 2004). There is a close relationship between NPC function and 
transcription activation indicating that transcription and mRNA export are coupled processes 
(Aguilera, 2005; Schmid et al., 2006). Interestingly, genetic depletion of Nup214 in mice 
provoked nuclear poly(A)+ RNA accumulation (van-Deursen et al., 1996). The yeast 
counterpart Nup159 is also required for poly(A)+ RNA export (Belgareh et al., 1998). Forler 
and co-workers found in Drosophila that dsRNA mediated depletion of either Nup358 or 
Nup214 provoked accumulation of poly(A)+ RNA suggesting that mRNA export is blocked in 
the absence of these Nups. hsp70 mRNA accumulated in the nucleus as well on Nup358 
dsRNA treated cells after heat shock. But a moderate reduction of cytoplasmic mRNAs was 
found upon Nup358 depletion. It is not clear whether this reflects a failure in NPC 
translocation or an indirect cellular response as a consequence of a defective NPC. The NE 
localization of NFX1 and the delayed mRNA export found on a stress response suggests that 
Nup358 plays a supporting role by favoring recycling of receptors. Based on our finding 
concerning the different behavior of large complexes on transport, we predict that the size of 
mRNPs may influence export dynamics and propose that a detailed study on the role of 
Nup214 on export mRNA should be performed taking these factors into consideration. 
 
6. Is the Nup214/Nup88 interaction at the NPC required for gating? 
 
Mathematical modeling of nuclear translocation predicts three major classes of transport: 
partitioning, enhanced diffusion and NPC gating (Becskei and Mattaj, 2005). The partitioning 
model is related to the traditional well-supported hydrophobic exclusion and virtual gating 
models (Jaggi et al., 2003; Ribbeck and Görlich, 2002; Rout et al., 2003). Enhanced diffusion  
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Figure 1. NPC gating model. Side (A) and top (B) view representation of the NPC showing two 
conformations: closed (top) and gated (bottom). Nup stoichometry is based on (Cronshaw et al., 2002). 
Note the actual exclusion diameter (black) is increased upon gating (Full-colour image in cover). 
 
and NPC gating are less consolidated and postulate that, in order to accomplish otherwise 
unlikely transport reactions, the NPC changes its properties favoring transport complex 
translocation. While enhanced diffusion does it by modulating the domain interactions within 
the meshwork, NPC gating requires a conformational change. No experimental evidence 
supports the enhanced diffusion model. The size of the 60S preribosomal subunit complex is 
close to the exclusion size limit of the NPC (Feldherr and Akin, 1990), suggesting that a major 
change of NPC characteristics may be required to accommodate translocation of large cargoes. 
We have shown that, while small GFP reporter derivatives are not affected, a 100-fold larger 
cargo fails to export in the absence of Nup214/Nup88 subcomplex (Chapter 4). Furthermore 
we revealed that just the small Nup214 domain that interacts with its neighbor Nups is 
sufficient to mediate 60S export suggesting that this can not occur by altering the 
characteristics of the NPC at a molecular level but at a supramolecular level. We propose that a 
NPC gating mechanism is required for export of preribosomes and that Nup214 plays an 




mediating, in a hinge like manner, transition between NPC conformational states (Figure 1). 
Our data represent evidence supporting this model and several microscopy studies have shown 
structural changes that alter the permeability of the NPC (Beck et al., 2004; Jaggi et al., 2003; 
Kiseleva et al., 1998; Stoffler et al., 2003). 
Several lines of evidence suggest that NPC gating may be dependent on Ca2+ levels (Stoffler et 
al., 1999) and a study on Saccharomyces cerevisiae revealed changes in cargo exclusion size 
upon treatment of cells with aliphatic alcohols which alter NPC properties (Shulga and 
Goldfarb, 2003). Based on this, we predict that intracellular calcium depletion would prevent 
NPC gating. Investigation on the gating mechanism is necessary to further determine if it is 
required for all large cargoes, if it is directional, if it requires energy, which other Nups are 
required and, if so, which are able to initiate it.  
 
7. What are the roles of Nup214 and Nup88 in cancer? 
 
Although higher content of Nups can be related to an increased cell metabolism and 
proliferation (Feldherr and Akin, 1993), the finding that Nup88 levels are high in relation to 
other Nups in more aggressive tumors is intriguing (Agudo et al., 2004). Nup88 and Nup214 
are closely co-regulated (Chapter 2 and (Perou et al., 1999; Ross et al., 2000), suggesting that 
both components are required for tumor development. Nup214 is frequently found in leukemia 
associated chromosomal translocations (Fornerod et al., 1995; Kraemer et al., 1994; von 
Lindern et al., 1992; von Lindern et al., 1990) and both components of the Nup214/Nup88 
subcomplex are highly expressed in leukemias (Perou et al., 1999; Ross et al., 2000).  
Recently, an episomal aberration was found in Acute Lymphoblastic Leukemia (ALL) that 
expresses a fusion between NUP214 and ABL1 and, as a consequence, a constitutively 
activated tyrosine kinase NUP214-ABL1 is overexpressed (Graux et al., 2004). In contrast to 
other Nup214 and Nup translocations, NUP214-ABL1 product lacks most of the FG-repeats 
indicating that the mechanism of oncogenesis may differ to that previously suggested (Kasper 
et al., 1999). Abl autophosphorylation is a prerequisite for activation (Brasher and Van Etten, 
2000) and it has been shown that oligomerization of fusion kinases can induce constitutive 
kinase activity (Golub et al., 1996). This suggests that Nup214 coiled coils may allow 
NUP214-ABL to oligomerize and provide capacity to autophosphorylate. We analyzed the 
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localization and function of this product as well as deletion derivatives containing either the 
amino-terminal, central or carboxy-terminal domains of Nup214. Irrespective of the presence 
of the coiled coils, none of the deleted constructs were capable to induce transformation of 
Ba/F3 cells (Chapter 6, Fig. 4), indicating that, in contrast to TEL-ABL1 fusion (Golub et al., 
1996), coiled coils mediated oligomerization is not sufficient for transformation. Intriguingly, 
immunofluorescence results clearly show that, as it was for all NUP214-ABL1 positive cell 
lines, all constructs that contained the coiled coils could incorporate to the NPC (Chapter 6, Fig 
1 and 2). In contrast, only full-length NUP214-ABL1 was autophosphorylated and could 
phosphorylate the downstream Abl target ERK2 (Chapter 6, Fig. 5). Surprisingly another 
phosphorylated target was detected when constructs contained Nup214 coiled coils: Nup358 
(Chapter 6, Fig 4 and not shown). This result suggests that derivatives containing the coiled 
coils have kinase activity, as they phosphorylate Nup358, but fail to target themselves and 
downstream oncogenic targets. We propose that, instead of oligomerization, the coiled coils 
domain of Nup214 provides a platform that permits, within the symmetry of the NPC, 
proximity between neighbor Abl1 molecules and activation. Supporting this fact is the capacity 
of all coiled coils containing constructs to co-precipitate with all Nup214 neighbor Nups 
(Chapter 6, Fig 3 and not shown). This hypothesis would reason that deleted constructs are not 
close enough for autophosphorylation and oncogenic activation. We propose to study this 
hypothesis at the molecular level through rapamycin-induced heterodimerization of Nup214 
with free Abl1 and/or FRET (Fluorescence Resonance Energy Transfer) and proximity 
techniques. Phosphorylation on Nup358 tyrosine was never reported. It is unknown whether 
this has any effect on Nup358 function and oncogenesis. We found no change in the 
localization of Nup358 in NUP214-ABL1 positive cell lines suggesting that phosphorylation 
does not prevent its incorporation to the NPC (Chapter 6, Fig 6). Further research is required to 
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Resumen en castellano para no científicos 
 
 
Resumen en castellano para no científicos 
 
La célula es la unidad vital porque es la estructura mínima capaz de realizar las funciones 
biológicas tanto en organismos unicelulares como pluricelulares. Cada célula esta aislada del 
exterior por una membrana celular. En su interior contiene su información genética en su 
Ácido DesoxirriboNucleico (ADN) y distintos tipos de orgánulos que realizan diversas 
funciones, como, por ejemplo, el metabolismo energético. Las proteínas son el resultado de la 
expresión del ADN y cumplen las funciones necesarias para mantener la célula viva 
construyendo la estructura de los orgánulos celulares y catalizando reacciones bioquímicas. A 
su vez, construyen la maquinaria necesaria para que el propio ADN se exprese y se duplique en 
cada división celular. La síntesis de proteínas requiere dos procesos principales: la 
transcripción y la traducción. La transcripción es el proceso por el cual, a partir del ADN, se 
sintetiza una molécula de Acido RiboNucleico (ARN), denominada ARN mensajero, que es el 
encargado de transmitir la información que se encuentra codificada en los genes. Esta 
información será convertida a proteína mediante la traducción del código genético presente en 
el ARN mensajero. Este proceso se lleva a cabo en los ribosomas, factorías biológicas de 
proteínas.  
Los seres vivos se clasifican, según su estructura celular, en procariotas y eucariotas. A 
diferencia de la célula procariota, la célula eucariota ha desarrollado un sistema de membranas 
y de compartimentalización celular que le ha permitido realizar procesos más complejos. Los 
orgánulos celulares están embebidos en un sistema de membranas en el citoplasma de la célula 
mientras que el ADN se encuentra en un núcleo separado del citoplasma por la envoltura 
nuclear. Se considera que esta adaptación evolutiva ha servido para proteger el cada vez más 
complejo material genético de agentes que lo dañen, como virus o agentes mutágenos. Pero 
esta adaptación conlleva otra serie de dificultades. Las células eucariotas han separado la 
transcripción, que ocurre en el núcleo, de la traducción, que ocurre en el citoplasma. Además, 
la expresión genética está regulada por señales recibidas del exterior de la célula. Para poder 
transmitir estas señales a su diana, el ADN, la célula provoca una cascada de reacciones que 
desemboca en la activación de factores de transcripción que promueven la expresión de genes 
determinados. Estos procesos requieren que el ADN sea accesible en determinadas 
circunstancias. Por otro lado, los ribosomas, encargados de producir proteínas en el citoplasma, 
están compuestos ellos mismos de proteínas y de ARN (ARN ribosómico) y su síntesis es un 
proceso complejo que se inicia en el núcleo y concluye en el citoplasma. Es evidente que, a 
pesar de aislar su ADN, la célula eucariota necesita mantener un sistema efectivo de 
comunicación entre el núcleo y el citoplasma. Si la envoltura nuclear supone una barrera que 
aísla el núcleo del citoplasma, ¿Cómo consigue mantener la célula esta comunicación? El 
complejo del poro nuclear lo permite reservando a su vez su derecho de admisión, ya que 
mantiene elementos indeseables excluidos del núcleo. 
Los poros nucleares son complejos de múltiples proteínas que atraviesan la envoltura nuclear 
creando un canal entre el núcleo y el citoplasma (Ver representación en el Chapt. 2, Fig. 2, pág. 
17). Los poros nucleares son uno de los complejos proteínicos mas grandes de la célula. Sus 
componentes se denominan nucleoporinas y en el caso de vertebrados, cada poro nuclear 
contiene unas 35 nucleoporinas (Ves lista de nucleoporinas en el Chapt. 2, Tabla 1, pág. 18) 
presente en múltiples copias siguiendo dos simetrías respecto al plano de la envoltura nuclear, 
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una rotacional de base 8 en el plano perpendicular, y una horizontal en el plano paralelo (Ver 
imagen de microscopio electrónico en Chapt. 2 Fig. 1, pág. 16).  
La envoltura nuclear y los poros nucleares se desmontan y se vuelven a formar cada vez que la 
célula se divide. Además, células con un alto metabolismo o actividad requieren un alto 
número de poros nucleares. Por ello y debido a su complejidad, la síntesis y el ensamblaje de 
esta estructura debe estar regulado de manera precisa. Las nucleoporinas se asocian en 
subcomplejos que actúan como bloques construyendo el complejo final. Unos de esos 
subcomplejos es el formado por las nucleoporinas Nup88 y Nup214. El gen NUP214 fue 
descubierto y caracterizado a partir de investigaciones en Leucemias (una forma de cáncer de 
glóbulos blancos) y fue denominado inicialmente Caín, debido a su proximidad al gen ABL 
(Abel). Por otro lado, se cree que la nucleoporina Nup88 también está relacionada con cáncer 
puesto que ha sido asociada a tumores agresivos. 
El paso de una molécula o cargo por el complejo del poro nuclear se denomina transporte 
núcleo-citoplasmático y se clasifica en importación, cuando es desde el citoplasma al núcleo, y 
exportación, cuando es desde el núcleo al citoplasma (Ver representación en la Chapt 2, Fig. 3, 
pág. 21). Además de la estructura del complejo del poro nuclear, el transporte núcleo-
citoplasmático requiere elementos adicionales. Entre ellos están los receptores de transporte, 
que son las únicas moléculas que son capaces de interaccionar con el poro nuclear y por ello 
mediar el transporte de ellas mismas y de los cargos a los que se asocian. Se dividen en 
importinas y exportinas según su función y reconocen y se unen a determinadas señales 
presentes en los cargos o elementos a transportar. Un ejemplo de exportina es CRM1, un 
receptor que es capaz de unirse a proteínas que contienen unas señales denominadas señales de 
exportación nuclear (NES), formando un complejo trimérico en presencia de RanGTP. Una vez 
transportado al citoplasma, este complejo se separa liberando el cargo en su destino (Ver 
animación junto al número de página). Ciertos virus son capaces de utilizar esta maquinaria 
para salir y entrar en el núcleo cuando lo requieren. 
A pesar de todos los avances conseguidos en los últimos años, todavía quedan muchas 
preguntas sin responder en el campo de los poros nucleares y el transporte entre el núcleo y el 
citoplasma. Se desconoce cómo una sola estructura es capaz de transportar cargos de tan 
diferente naturaleza que van desde pequeños solutos hasta un ARN mensajero o un 
preribosoma, cuyo tamaño está al límite del tamaño de exclusión del poro nuclear. Además, 
todavía no se ha determinado cual es la función específica, si la hay, de cada uno de los 
componentes del complejo en el transporte de los distintos cargos. Aunque se cree que su 
superficie hidrofóbica permite la interacción con el poro, se desconoce también cómo los 
receptores de transporte son capaces de atravesar el poro nuclear. Aunque se han propuesto 
diversos teorías, todavía no se ha definido un modelo de transporte único capaz de abarcar 
todas las modalidades de transporte encontradas y se cree que distintos mecanismos de 
transporte co-existen en una misma estructura. Determinar cómo se regula la función del 
complejo del poro nuclear y cómo se realiza el transporte núcleo-citoplasmático es de gran 
importancia para conocer funciones básicas de la célula y entender su biología tanto en 
condiciones de salud como de enfermedad. 
El trabajo presentado en este libro es el producto de un proyecto destinado al estudio de los 
poros nucleares y transporte núcleo-citoplasmático. Hemos estudiado tres nucleoporinas: 
Nup88, Nup214 y Nup358, y hemos completado el estudio de su localización exacta respecto 
del resto del poro utilizando técnicas de microscopia electrónica (Chapter 3). Nup358 es el 
principal componente de los filamentos citoplasmáticos del poro y descansa sobre el complejo 
Nup88-Nup214 que se encuentra mas próximo al canal central. Para estudiar estas 
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nucleoporinas en detalle, hemos utilizado una técnica denominada interferencia de RNA, que 
promueve la destrucción de un RNA mensajero específico y con ello reduce el contenido 
celular de la proteína que codifica. Hemos sido capaces de reducir dramáticamente los niveles 
endógenos de cada una de estas nucleoporinas o Nups. Hemos estudiado entonces qué sucede a 
la célula y a las otras Nups con técnicas de microscopía confocal que permiten estudiar 
estructuras intactas en tres dimensiones en células incluso vivas. Hemos descubierto que 
Nup358 necesita la presencia del complejo Nup88/Nup214 para incorporarse al poro nuclear y 
que estas dos Nups, Nup88 y Nup214, presentan co-dependencia, tanto para mantener su 
estabilidad como para incorporarse al poro nuclear. La localización de estas tres Nups sugiere 
que desempeñan una función en el mecanismo de importación. Sin embrago, ciertas 
investigaciones excluyen esta posibilidad. Hemos analizado si Nup88, Nup214 y Nup358 están 
implicadas en el mecanismo de exportación y hemos encontrado que así es. Nup358 tiene una 
función de apoyo en el mecanismo de exportación mediado por la exportina CRM1. Gracias a 
Nup358, el complejo de exportación, formado por CRM1, RanGTP y un cargo, se separa. Este 
proceso permite la liberación del cargo y ayuda a reciclar CRM1 al núcleo para otra ronda de 
exportación, consiguiendo un transporte más eficiente. 
Hemos estudiado la naturaleza de las señales de exportación (Chapter 4) por técnicas de 
bioquímica y biología molecular y celular. Hemos creado señales artificiales que presentan alta 
afinidad por CRM1 (suprafisiológicas) y hemos concluido que la afinidad de las señales de 
exportación endógenas por CRM1 debe ser baja en condiciones normales de lo contrario el 
complejo de exportación es desensamblado menos eficientemente. Este estudio ha servido para 
definir más claramente la función de Nup358 en exportación nuclear mediada por CRM1. 
El receptor de exportación CRM1 es capaz de interaccionar con nucleoporinas del poro 
nuclear. De todas las Nups, Nup214 es con la que interacciona con mayor afinidad. Debido a 
esto, hemos estudiado en más detalle la función de Nup214 en la exportación mediada por 
CRM1. Hemos analizado la capacidad de exportación de una serie de cargos en células a las 
que se ha reducido el contenido de Nup214 por técnicas de RNAi (Chapter 5). 
Sorprendentemente, no hemos encontrado ningún defecto en exportación de GFP o Rev-GFP, 
dos cargos de pequeño tamaño. Sin embrago, el defecto en exportación es evidente cuando 
estudiamos la exportación del preribosoma, un cargo de gran tamaño. Nuestro estudio muestra 
que los mecanismos de transporte son diferentes dependiendo del cargo a pesar de utilizar el 
mismo receptor de exportación. También muestra que Nup214 juega un papel importante en la 
exportación de este cargo específico. Creemos que este tipo de exportación es ejecutado para 
cargos de gran tamaño y que requiere un proceso que ha sido denominado apertura, que supone 
un cambio estructural en el poro nuclear para acomodar el paso de grandes cargos (Ver 
representación en Chapt. 7, Fig.1, pág 116 y en portada). 
Muy recientemente, una mutación que implica los genes ABL y Nup214 ha sido definida en un 
subtipo de Leucemias. Actualmente y en un intento de mejorar las terapias para este tipo de 
enfermedad, estamos investigando el mecanismo de transformación tumoral provocado por 
esta mutación (Chapter 6). 
En conclusión, el trabajo presentado en esta tesis ha contribuido en un mejor conocimiento del 
complejo del poro nuclear y, en definitiva, de la biología de la célula y es de potencial interés 
por su aportación a la sociedad en general y al mundo de la biomedicina en particular. 
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List of abbreviations 
 
NPC Nuclear Pore Complex 
 
NE Nuclear Envelope 
 
NLS Nuclear Localization Signal 
 
NES Nuclear Export Signal 
 
GTP Guanosine TriPhosphate 
 
GDP Guanosine DiPhosphate 
 
FG Phenylalanine Glycine 
 
RanBP Ran Binding Protein 
 
RNAi Ribonucleic Acid Interference 
 
tRNA Transfer Ribonucleic Acid 
 
rRNA Ribosomal Ribonucleic Acid 
 
mRNA Messenger Ribonucleic Acid 
 
snoRNA Small Nucleolar Ribonucleic Acid 
 
EM Electronic Microscopy 
 
TEM Transmission Electronic Microscopy 
 
FESEM Field Emission Scanning Electronic Microscopy 
 
ProtA Protein A 
 
GFP Green Fluorescent Protein 
 
FRAP Fluorescence Recovery After Photobleaching 
 
FRET Fluorescence Resonance Energy Transfer 
 
LMB Leptomycin B 
 
CML Chronic Myeloid Leukemia 
 
AML Acute Myeloid Leukemia 
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